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Abstract 
Poly(dimethylsiloxane) or PDMS is one of the materials of choice to be used in 
implants due to some of its properties, such as low-cost, versatility, elasticity, chemical 
inertness, biocompatibility, non-toxicity, among others. However, PDMS also presents 
some drawbacks. The major limitation of PDMS is its hydrophobic nature, which makes 
the transferring and spreading of aqueous solutions difficult and may lead to 
complications in cell culture, as well as its low adhesiveness for cell attachment. 
The PDMS used in the current work was modified by atom transfer radical 
polymerization (ATRP), which is a technique used to carry out a controlled/living radical 
polymerization that is easy to apply and makes possible the use of different monomers 
and reaction media. The surface was coated with poly(ethylene glycol) methyl 
methacrylate (PEGMA), a polymer known for its ability to reduce biomolecules 
adsorption. With this coating, anti-fouling properties are expected, as well as a more 
hydrophilic surface. Contact angles were measured showing that the PEGMA coating 
turned the surface more hydrophilic. Moreover, by atomic force microscopy the surface 
topography was assessed. It was possible to observe that the coating possessed a 
high roughness, thus suggesting that ATRP is a suitable technique to create brushes in 
the PDMS surface. However, the contact angle variability that was found in the 
modified PDMS samples suggests that the technique is not reproducible. 
The interaction of the modified PDMS with human skin fibroblasts (HSkF) and 
human umbilical vein endothelial cells (HUVECs) was assessed in order to determine 
the biocompatibility of the surface. To observe these interactions, an 
immunocytochemistry assay was used to stain the cell nuclei and the vinculin and 
fibronectin complexes. The stained structures were visualized with confocal 
microscopy. The staining of the cell nuclei made possible the estimate of the number of 
cells in the surface, and the formed fibronectin was also quantified. Some colorimetric 
assays were also performed (MTT and CV) to quantify the metabolic activity per cell, 
giving some insight about cell viability and adhesion. 
 It was possible to conclude that the modified surfaces decrease cell adhesion, 
which is expected due to the anti-fouling properties of PEGMA. Then, if an increase in 
cell adhesion is desired, PDMS coated with PEGMA is not the most suitable material 
for vascular implants. However, due to the anti-fouling properties, a better 
hemocompatibility can be achieved. 
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Resumo 
O poli(dimetilsiloxano) ou PDMS é um dos materiais de eleição no 
desenvolvimento de implantes devido a algumas das suas propriedades, tais como 
baixo-custo, versatilidade, elasticidade, inércia química, biocompatibilidade, não 
toxicidade, entre outras. No entanto, o PDMS apresenta algumas desvantagens. A 
maior limitação do PDMS é a sua natureza hidrofóbica, a qual pode levar a 
complicações na cultura de células, bem como a sua reduzida aderência para a 
adesão celular. 
 O PDMS usado neste trabalho foi previamente modificado por polimerização 
radicalar controlada por transferência de átomo (ATRP), que consiste numa técnica 
usada para levar a cabo uma polymerização radicalar controlada fácil de aplicar e que 
torna possível o uso de diferentes monómeros e meios de reacção. A superfície foi 
revestida com poli(etileno glicol) metil metacrilato (PEGMA), um polímero conhecido 
pela sua capacidade de reduzir a adsorção de biomoléculas. Com este revestimento, 
esperava-se a obtenção de uma superfície anti-adesiva  e mais hidrofílica. Os ângulos 
de contacto foram medidos confirmando que  o revestimento tornou a superfície mais 
hidrofílica. Adicionalmente, a topografia da superfície foi avaliada por microscopia de 
força atómica (AFM). Observou-se que o revestimento apresenta uma elevada 
rogusidade, mostrando que o ATRP é uma técnica apropriada para criar “escovas” na 
superfície do PDMS. No entanto, as grande variabilidade dos ângulos de contacto 
medidos no PDMS modificado indicam que a técnica não é reprodutível. 
 A interacção do PDMS modificado com fibroblastos da pele humana (HSkF) e 
células endoteliais da veia do cordão umbilical humano (HUVECs) foi avaliada de 
modo a determinar a biocompatibiltidade da superfície do material em estudo. De 
modo a observar as interacções, utilizou-se técnicas de imunocitoquímica que 
permitiram marcar o núcleo celular e complexos de vinculina e fibronectina com 
fluorescência. As estruturas marcadas foram visualizadas com micorscopia confocal. A 
marcação do núcleo celular permitiu estimar o número de células na superfície, e a 
fibronectina formada foi também quantificada. Alguns estudos colorimétricos foram 
também utilizados (MTT e CV) com o intuíto de quantificar a actividade metabólica por 
células, fornecendo informação acerca da viabilidade e da adesão celular. 
 Foi possível concluir que a superfície modificada diminui a adesão celular, o 
que era expectável devido às propriedades anti-adesivas do PEGMA. Assim sendo, se 
um aumento na adesão celular for desejado, o PDMS revestido com PEGMA não é o 
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material mais apropriado para implantes vasculares. No entanto, devido às 
propriedades anti-adesivas, uma melhor hemocompatibilidade pode ser alcançada. 
ix 
 
List of Contents 
Acknowledgments                          iii  
Abstract                            v 
Resumo                          vii 
List of Contents                          ix 
List of Figures                           xi 
List of Tables                          xv 
List of Abbreviations                        xvii 
Framework                         xix 
Chapter 1. Introduction                        1 
1. Vascular implants                           2 
2. Silicone Biomaterials                       3 
2.1. Properties                           4    
2.2. Poly(dimethylsiloxne) (PDMS)                        5 
2.3. Applications                          6 
3. Surface Modification                          8 
3.1. Physical Treatments                         8 
Plasma Treatment                         9 
3.2. Chemical Treatments                         9 
Surface Grafting                       10 
Atom Transfer Radical Polymrization (ATRP)                   11 
3.3. Coating Materials                        12 
3.4. Vascular Grafts Modification           13 
4. Body-Biomaterial Interactions                       14 
4.1. Cell-Biomaterial Interaction                      15 
4.1.1. Extracellular Matrix (ECM)                      16 
4.1.2. Adhesion Molecules – Integrins                     18 
4.2. Adhesion Proteins                       19 
 x 
 
4.3. Host Immune Response                       20 
Chapter 2. Materials & Methods                       23 
1. Surface Modification             24 
 1.1. Fibronectin Coating             24 
 1.2. Gelatin Layer             24 
2. Surface Characterization                         24 
2.1. Contact Angles                    24 
2.2. Atomic Force Microscopy (AFM)                      25 
3. Surface Cytotoxicity             26 
3.1. MTT Assay                        28 
3.2. Crystal Violet (CV) Assay                      28 
4. Cell-Biomaterial Interaction                       28 
3.1. Cell Culture                        28 
3.1.1. Specific conditions                       30 
3.2. Cell Interaction with Modified and Unmodified PDMS                   30 
3.2.1. Immunocytochemistry Assay                      32 
3.2.2. Confocal Microscopy                       33 
5. Statistics               34 
Chapter 3. Results & Discussion                       35 
1. Surface Characterization                        35 
1.1. Contact Angles                        35 
1.2. AFM              36 
2. Surface Cytotoxicity             39 
3. Cell-Biomaterial Interaction                       44 
Chapter 4. Conclusions                        55 
Chapter 5. Recommendations and future work                      57 
References                           59 
xi 
 
List of Figures 
Figure 1. Repeat unit of siloxane and of PDMS. [Taken from (1)]        (4) 
Figure 2. Surface grafting of a generic surface. On the top figure it is possible to 
observe a representation of the grafting on approach. In the bottom the grafting from 
approach is represented. [Taken from (33)]         (10) 
Figure 3. Schematic representation of the ATRP process. After the initiator (X) covers 
the polymer surface (R), the transition metal complex (Met) will remove the halides 
from the polymer surface. The monomer (M) will then interact with the polymer surface 
and the propagation of the monomers begins, culminating with the formation of 
polymeric chains in the polymer surface. [Taken from (33)]       (12) 
Figure 4.  Progression of the mammalian cell adhesion. (A) Initial contact of the cell 
with the material covered by proteins. (B) Formation of bonds between the cell surface 
receptors and the cell adhesion ligands in the proteins. (C) Cytoskeletal reorganization 
with a progressive spreading of the cell in the surface of the implant, increasing the 
attachment strength. [Taken from (1)]          (15)    
Figure 5. Cell proteins involved in cell adhesion on a biomaterial. [Taken from (50)]   (16) 
Figure 6. Surface placed in a protein mixture. In a matter of seconds the surface is 
covered by a layer of adsorbed proteins. Initially, the “red” and the “green” proteins 
adsorb in a higher concentration. With time, these proteins are displaced by the “blue” 
protein. This can happen because the concentration of proteins in the adsorbed layer is 
usually different from the concentration in the solution, being able to change in time. 
[Taken from (47)]                      (19) 
Figure 7. The top scheme shows a protein denaturing with increasing adsorption time. 
The bottom scheme shows a proteins adsorbing to the surface in different orientations. 
This is possible because the conformation and the orientation of adsorbed proteins 
depend on adsorption conditions and surface properties. [Taken from (47)]               (20) 
Figure 8. Reaction of the host to the implanted biomaterial. (1) The biomaterial is 
implanted in the surgical site by the surgeon. (2) A layer of proteins quickly adsorbs to 
the implant surface. (3) The neutrophils and the macrophages examine and attack the 
biomaterial. However the implant is too large to be ingested. (4) The macrophages find 
that they cannot digest the implant, so they fuse into giant cells to engulf the implant. 
 xii 
 
The giant cells send out cytokines to attract other cells. (5) The fibroblasts arrive and 
start synthesizing collagen. (6) The implant is completely entrapped in an acellular, 
avascular collagen bag. [Taken from (47)]         (21) 
Figure 9. Representation of poly(ethylene glycol) methyl methacrylate (PEGMA) 
polymer brushes formed in the PDMS surface due to the ATRP modification. [Taken 
from (60)]             (23) 
Figure 10. Water drops formed in the surface. Contact angle between the water drop 
and the surface depends on the surface hydrophobic/hydrophilic character. [Taken 
from (61)].             (25) 
Figure 11. Scheme of the cytotoxicity assessment experiment. First, samples were cut 
into 4 small squares (1 cm2). One of the samples was washed and the other was only 
sterilized. The 4 squares of each sample were placed in a 12 well-plate and the cells 
were seeded.                (26) 
Figure 12. Schematic representation of the 96 well-plate used to seed the cells. Cells 
were seeded in a concentration of 5 x 104 cells/ml. After 24 h the medium was 
changed. Row A: medium incubated with the washed modified PDMS in the first 12 
well-plate. Row B: medium incubated with the non-washed modified PDMS in the first 
12 well-plate. Row C: medium incubated with the washed modified PDMS in the 
second 12 well-plate. Row D: medium incubated with the non-washed modified PDMS 
in the second 12 well-plate. Row E: medium incubated with the washed modified 
PDMS in the third 12 well-plate. Row F: medium incubated with the non-washed 
modified PDMS in the third 12 well-plate. Row G: control with fresh medium.           (27) 
Figure 13. Distribution of PDMS samples in the 12 well-plate, for the experiments with 
HSkF. The first 4 wells contain unmodified PDMS surfaces, the next 4 contain modified 
PDMS surfaces and the last 4 wells contain modified PDMS with a fibronectin coating. 
The 12 well-plate was prepared in duplicate, one to be incubated for 48 h and the other 
for 120 h.             (31) 
Figure 14. Distribution of PDMS samples in the 12 well-plate, for the experiment with 
HUVECs. In the left plate, the first 4 wells contain unmodified PDMS surfaces, the next 
4 contain modified PDMS surfaces and the last 4 wells contain modified PDMS with a 
fibronectin coating. In the second plate, the first 4 wells contain modified PDMS with a 
gelatin coating. Both the 12 well-plate were prepared in duplicate, one to be incubated 
for 48 h and the other for 120 h.          (31) 
xiii 
 
Figure 15. Distribution of PDMS samples in the 12 well-plate, for the second 
experiment with HUVECs. In the left plate, the first 4 wells contain unmodified PDMS 
surfaces with adsorbed fibronectin, the next 4 contain modified PDMS surfaces with 
adsorbed fibronectin and the last 4 wells only contain a fibronectin coating. In the 
second plate, the first 4 wells have no additional surface or coating. Both the 12 well-
plate were prepared in triplicate, one to be incubated for 3 days, the other for 4 days 
and the last for 5 days.                     (32) 
Figure 16. Scheme representing the image processing for cell number quantification. 
(A) image stack (B) overlay image (C) selection of DAPI staining fluorescence (D) 
particle analysis image. [Taken from (60)]         (33) 
Figure 17. Images obtained by atomic force microscopy (AFM) from the modified 
PDMS without (left) and with (right) a fibronectin coating. Both the pictures correspond 
to an area of 5 x 5 μm. Surface roughness is represented between 0 and 200 μm.
                        (37) 
Figure 18. Images obtained by atomic force microscopy (AFM) from the modified 
PDMS with a fibronectin coating after cell seeding. The picture on the left has a normal 
resolution and corresponds to an area of 5 x 5 μm. The picture on the right is a 3D 
picture from a high resolution picture taken from the surface.                (38) 
Figure 19. Ratio between the MTT values and CV values for each dilution of the 
medium in contact with washed and non-washed modified PDMS surfaces. Control 
consists of the fibroblasts seeded in fresh medium. Results correspond to the average 
of 3 independent assays ± standard deviation.                           (39) 
Figure 20. Ratio between the MTT values and CV values for each dilution of the 
medium in contact with washed and non-washed modified PDMS surfaces. Control 
consists of the HUVECs seeded in fresh medium. Results correspond to the average of 
3 independent assays ± standard deviation.         (41) 
Figure 21. Ratio between the MTT values and CV values for each dilution of the 
medium in contact with washed and non-washed modified PDMS surfaces. Fibroblasts 
were seeded with medium that was previously incubated with modified PDMS and 
diluted afterwards. Control consists of the fibroblasts seeded in fresh medium. Results 
correspond to the average of 3 independent assays ± standard deviation.     (42) 
Figure 22. Ratio between the MTT values and CV values for each dilution of the 
medium in contact with washed and non-washed modified PDMS surfaces. HUVECs 
 xiv 
 
were seeded with medium that was previously incubated with modified PDMS and 
diluted afterwards. Control consists of the fibroblasts seeded in fresh medium. Results 
correspond to the average of 3 independent assays ± standard deviation.                (43) 
Figure 23. Images obtained by confocal microscopy of the immunochemistry assay 
conducted after exposing fibroblasts to the modified PDMS for 48 and 120 h. A and B - 
fibroblasts adhered to unmodified PDMS, after 48 and 120 h, respectively. C and D - 
fibroblasts adhered to modified PDMS, after 48 and 120 h, respectively. E and F - 
fibroblasts adhered to modified PDMS with a fibronectin coating, after 48 and 120 h, 
respectively.                           (45) 
Figure 24. Average number of nuclei counted after 48 and 120 h of cells exposure to 
unmodified PDMS, modified PDMS and modified PDMS with a fibronectin coating. 
Results correspond to the average of 6 counts ± standard deviation.               (47) 
Figure 25. Estimate of the fibronectin percentage present after 48 and 120 h using 
unmodified PDMS, modified PDMS and modified PDMS coated with fibronectin. 
Results correspond to the average of 6 experiments ± standard deviation.     (48) 
Figure 26. Images obtained by confocal microscopy of the immunochemistry assay 
conducted after exposing HUVECs to the modified PDMS for 48 and 120 h. A and B - 
HUVECs adhered to unmodified PDMS, after 48 and 120 h, respectively. C - HUVECs 
adhered to modified PDMS, after 48 h. D - HUVECs adhered to modified PDMS coated 
with fibronectin after 48 h. E and F - HUVECs adhered to modified PDMS coated with 
gelatin, after 48 and 120 h, respectively.           (49) 
Figure 27. Images obtained by confocal microscopy of the immunochemistry assay 
conducted after seeding the HUVECs in different surfaces for 3, 4 and 5 days. A and B 
- HUVECs adhered to the 12 well-plate wells with no gelatin, after 3 and 5 days, 
respectively. C and D - HUVECs adhered to the 12 well-plate wells with gelatin, after 3 
and 5 days, respectively. E and F - HUVECs adhered to modified PDMS coated with 
gelatin after 3 and 5 days, respectively. G and H - HUVECs adhered to unmodified 
PDMS coated with gelatin, after 3 and 5 days, respectively. Pictures from day 4 are not 
represented, because they didn’t represent any additional information.      (52) 
 
 
xv 
 
List of Tables 
Table 1. Key milestones in the development of silicone. [Adapted from (1)]       (4) 
Table 2. Applications of silicone biomaterials in the biomedical field. [Adapted from (3)]
                          (7) 
Table 3. Contact angles measured for the modified and unmodified PDMS. Results 
represent the average of 5 (modified PDMS) and 2 (unmodified PDMS) independent 
measures ± standard deviation.          (35) 
 
 
 xvi 
 
xvii 
 
Abbreviations 
GABGs- Coronary Artery Bypass Grafts  
VAGs- Vascular Access Graft  
PET- Polyethylene Terephthalate  
ePTFE- Expanded Polytetrafluoroethylene  
PU- Polyurethane  
PEtUs- Poly(ether)urethanes  
PDMS- Poly(dimethyl siloxane)  
UV- Ultraviolet  
ATRP- Atom Transfer Radical Polymerization  
PEGMA- Polyethylene Glycol Methyl Methacrylate  
PHEMA- Poly(2-hydroxyethyl methacrylate)  
PEO- Poly(ethylene oxide)  
PEG- Poly(ethylene glycol)  
ECM- Extracellular Matrix   
GAGs- Glycosaminoglycans   
RGD- Arg-Gly-Asp  
VEGF- Vascular Endothelial Cell Growth Factor  
FGF- Fibroblast Growth Factor  
EGF- Epithelial Cell Growth Factor  
FAK- Focal Adhesion Kinase  
HSkF- Human Skin Fibroblasts  
HUVECs- Human Umbilical Veins Endothelial Cells  
RPMI- Roswell Park Memorial Institute  
PBS- Phosphate Buffer Saline  
EDTA- Ethylenediamine Tetraacetic Acid) 
PFA- Paraformaldehyde  
BSA- Bovine Serum Albumin  
 xviii 
 
DAPI- 4',6-diamidino-2-phenylindole  
MTT- “3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyl‐tetrazolium bromide) 
CV- Crystal Violet  
xix 
 
Framework 
 
The cardiovascular diseases are becoming more and more common mostly due 
to the increasing use of blood-contacting devices. One example of cardiovascular 
interventions is the replacement of obstructed parts of arteries, which involves the use 
of vascular grafts. The most common materials used in the synthetic vascular grafts 
are the polyethylene terephthalate (PET), expanded polytetrafluoroethylene (ePTFE), 
but they present a thrombogenic nature that can cause serious complications. Thus, 
some alternatives have been studied, like the poly(dimethyl siloxanes) (PDMSs) that 
has been used for vascular vessels and as a coating, presenting some promising 
results. However, this material is hydrophobic, which will repel proteins from serum and 
consequently will decrease cell adhesion to the surface. Hence, some coating 
techniques like the ATRP can be used in order to modify the surface by covering it with 
hydrophilic brushes.   
The aim of this work is to evaluate the biocompatibility of modified silicone 
rubber for vascular applications. Specifically, this work aims to assess if the PDMS 
surfaces modified with polyethylene glycol methacrylate (PEGMA) brushes by atom 
transfer radical polymerization (ATRP) are suitable for vascular grafts applications. 
These modified surfaces were kindly provided by the Department of Biological 
Engineering, University of Minho, Portugal. The hydrophobicity of the modified surfaces 
will be determined, since the goal of the modification was to turn it more hydrophilic 
thus increasing the interaction of the biomaterial with endothelium cells. Cell-
biomaterial interactions will be studied and to enhance cell adhesion the surfaces will 
also be coated with fibronectin and gelatin. 
  
 xx 
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Chapter 1. Introduction      
 Biomaterials, that were unknown 50 years ago, are now widely used in 
medicine, dentistry and biotechnology. Back on that time, medical devices 
manufacturers, regulatory approval processes and the biocompatibility concepts did not 
exist. (1) The development of biomaterials was not based in any scientific criteria. On 
the contrary, when biomaterials were used to create new devices, these were tested on 
a trial-and-error basis using animals and even humans.  
 However, this scenario has changed dramatically due to the needs of the 
continuous and ever-growing practice of medicine, and currently there are thousands of 
biomedical devices. Besides the biomedical devices, diagnostic products, 
pharmaceutical preparations and disposable devices, now the list of biomaterials 
includes intelligent drug delivery, tissue culture, tissue engineering and hybrid organs. 
(2)  
The biomaterials can be divided into four major classes: polymers, metals, 
ceramics and natural materials. The polymers represent the major class of biomaterials 
and are used in several biomedical applications in the orthopedic, dental, soft tissue 
and cardiovascular areas. (1)  
Implants made of biomaterials can range from temporary implants, as venous 
catheters, to long-term implants, as artificial joints. It is highly probable that most 
individuals in developed countries will use biomaterials and medical devices at some 
point in their lives. (3) However, some implants and extracorporeal devices can have 
adverse interactions with the patient, which constitute a device failure, and thus can 
cause injury or death of the patient. These complications arise largely from the tissue-
biomaterial interaction and infection. (1)  
 Vascular implants (or grafts) are one type of implants that have been widely 
used in order to enhance the insufficient functioning of blood vessels. There are 
several types of vascular implants, which can be grouped in three main classes: 
coronary artery bypass grafts (CABGs); small-diameter grafts; and large-diameter 
grafts. The CABGs are used in aortocoronary bypass procedures and have a diameter 
between 1–4 mm. The small-diameter grafts (4 –6 mm) are used peripherally to relieve 
lower-extremity ischemia and as vascular access graft (VAG) to treat endstage renal 
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diseases. Regarding the large-diameter grafts (> 7 mm) are used in the thoracic and 
abdominal cavities, typically for the replacement of aortic sections. (3)  
1. Vascular implants 
The medicine practice has always involved the use of blood-contacting devices, 
such as the simple blood bags and catheters. Nowadays, these devices are even more 
present in our reality and in the so-called modern medicine, being more complex and 
intimately connected to cardiovascular diseases.  Cardiovascular diseases, which 
include any disorder that affects both the heart and the blood vessels, are one of the 
main causes of death in the World. (4) According to the World Health Organization 
(WHO), in 2002 there were 393.000 deaths caused by cardiovascular diseases in 
Portugal, and around 167 million deaths worldwide. The use of the blood-contacting 
devices is deeply connected to the cardiovascular diseases, thus being its major 
application in the biomedical field.  
The vascular grafts are included in the group of blood-contacting devices, being 
widely used to restore the blood flow in patients with different cardiovascular problems. 
The replacement of obstructed parts of arteries is becoming a very common medical 
procedure, so the use of vascular grafts is increasing.  
The ideal features of a vascular graft include an easy handling, mimicking the 
native blood vessels, being non thrombogenic, immunologically inert, resistant to 
infection and puncture trauma, being able to retain tensile strength, and being 
manufactured at reasonable costs. There are two main groups of vascular substitutes, 
the biological grafts and synthetic grafts. (5)  
The biological grafts or autografts consist in taking tissue from one site on a 
patient and transplant it to another site on the same patient.  Usually it consists in an 
autogenous vessel, like the saphenous or the arm veins. Currently, the autografts are 
the vascular grafts with the best performance. However, due to the unavailability, poor 
quality or the failure (thrombosis, emboli production, intimal hyperplasia) of autologous 
conduits, the use of prosthetic grafts is often required. (2; 6)  
The prosthetic grafts are manufactured from synthetic materials, like polyester 
and expanded polytetrafluoroethylene. (6) Regardless of being extremely useful and 
necessary these devices are not perfect, presenting some biocompatibility issues and 
some undesirable side effects, thus requiring the search for more suitable materials 
and alternative coating techniques. Though a large variety of polymeric materials are 
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used (e.g. polyethylene terephthalate (PET), expanded polytetrafluoroethylene 
(ePTFE) (7)), they present a thrombogenic nature that can cause serious 
complications, and consequently the failure of the devices. It is recognized that these 
materials have excellent mechanical and physical properties. Nevertheless, they are 
also characterized by some hemo-incompatibility, thus activating the humoral and 
cellular defense mechanisms of the body when contacting with blood. (4; 8) To 
overcome this biocompatibility problem, the patients are usually exposed to systemic 
anticoagulation regimens, which in a long-term situation can increase the probability of 
hemorrhage, even if the levels of anticoagulants are controlled. Indeed thrombosis is, 
for example, the cause of 80% of vascular graft dysfunction. In addition to this problem, 
there is a risk of damaging the endothelium lining of blood vessels during implantation 
of some devices like vascular grafts, which can lead to proliferation of smooth muscle 
cells or vascular stenosis (decrease in vessel diameter). (9) 
For that reason, searching for more suitable materials and coating techniques is 
highly recommended. Alternative polymers that have been studied are the 
polyurethane (PU) elastomers, which are thermoplastic polymers with outstanding 
physical properties. A group of the PU, the aromatic poly(ether)urethanes (PEtUs), due 
to their flex life, tensile strength, elongation and good blood compatibility, have been 
used as chorinc implants (e.g. ventricular assist devices, intra-aortic balloons). 
However, these polymers have been presenting variable clinical results, showing some 
thrombogenicity and tendency to degrade uncontrollably. (7) Furthermore, the 
poly(dimethyl siloxanes) (PDMSs) constitute another example of materials that have 
been used for vascular vessels and as a coatings, presenting some promising results 
(8). The PDMS presents better blood contact properties when compared to the PU. (7)  
2. Silicone Biomaterials 
 Silicones, or poly(diorganosiloxanes), are a class of synthetic polymeric 
biomaterials with high chemical stability that were not explored before 1940. Six years 
later this polymer was referred for the first time as suitable for biomedical applications, 
and nowadays is one of the materials that found several applications into the 
biomedical field being widely used as an implant or any other invasive device. (1; 3; 10) 
The key milestones in the development of silicone are represented in the Table 1. 
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Table 1. Key milestones in the development of silicone. [Adapted from (1)] 
Year Milestone 
1824 Silicon is discovered by Berzelius. It is obtained through the reduction of 
potassium fluorosilicate with potassium: 4K + K2SiF6         Si + 6KF.  
1863 Tetraethylsilane: the first silicon organic compound is synthesized by Friedel 
and Craft.  
1940 After Hide of Dow Corning demonstrates the thermal stability and the high 
electrical resistance of silicone resins, and Rochow of General Electric finds a 
method to separate silicone form silicon and methylchloride, silicones become 
commercial materials. 
2.1. Properties  
The silicone backbone consists in repeating silicon atoms bonded to oxygen 
atoms, with R groups (organic groups) attached to the silicon atom (Figure 1). (1; 11) 
Usually the organic groups are methyl groups, which gave origin to the name silicone. 
This happened because Kipping (1904) believed that there was a structural similarity 
with ketones, which was proved to be incorrect. However the name was kept. (1; 12)  
 
Figure 1. Repeat unit of siloxane and of PDMS. [Taken from (1)] 
There are several features that make this material suitable for biomedical 
applications, such as its good chemical and physical properties, its blood compatibility, 
low toxicity, good thermal and oxidative stability, low modulus and anti-adhesive 
properties. (1; 13; 14) It is the presence of organic groups attached to an inorganic 
backbone that provides excellent properties to the silicone, enabling this material to be 
used as a fluid, an emulsion, a compound, a resin or an elastomer. (1) Silicone finds 
many applications due to its hydrophobic nature, which makes it suitable to water 
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repellent applications. On the other hand, its low surface energy makes it suitable to 
applications where a material with non-stick characteristics is required. Furthermore, 
there are also many applications in the electronic field, due to the excellent dielectric 
properties exhibited by silicone. (12)  
However, silicone also presents some biocompatibility issues, due to the 
presence of siloxane oligomers or some catalyst residues that can diffuse out from the 
material and cause inflammation, and presents a surface that is difficult to modify due 
to its hydrophobic character. Also, silicone favors protein adsorption, which can cause 
problems like blood coagulation and biofilm formation. (10; 14)  
2.2. Poly(dimethylsiloxane) (PDMS) 
The most common poly(diorganosiloxane) structure is the 
poly(dimethylsiloxane) or PDMS (-Me2SiO-) (Figure 1), which was first used for external 
prostheses in 1960, and from then on has been one of the materials of choice to be 
used in implants. (3; 12; 15) PDMS is a linear silicone that is in the fluid state at room 
temperature and is soluble in organic solvents. Its physical properties depend widely 
from its molar mass. A low molar mass it’s in the origin of materials with low viscosity, 
and high molar mass materials have a viscoelastic behavior and are gum-like. (12) 
PDMS has a low surface tension (20.4 mN/m) and can wet most surfaces. Because of 
its methyl groups that point to the outside, PDMS gives rise to very hydrophobic films 
and presents a surface with good releasing properties. This material is widely used in 
many applications due to the characteristics mentioned above and due to its lack of 
toxicity. (1)  
The introduction of chemical crosslinks in this material enables the formation of 
silicone elastomers or rubbers. These materials present a high reversible extensibility, 
which is called rubberlike elasticity. Then, due to the resulting three-dimensional 
network, the silicone rubber only swells in organic solvents, thus it doesn’t dissolve 
anymore. The silicone resins, which present low extensibility and low degrees of 
swelling in the presence of organic solvents, are formed when there is a high 
crosslinking degree. Both the silicone fluids, elastomers and resins are highly stable. 
Their thermal stability is so high that they can support temperatures up to 250 °C in air 
and up to 350 °C in vacuum. (12)  
 PDMS shows several characteristics that makes it attractive for biomedical 
applications. It has a low-cost and presents versatility, elasticity, chemical inertness, 
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biocompatibility, non-toxicity, excellent optical properties, gas permeability, lack of 
autofluorescence, transparence down to 280 nm, reversible deformation. Moreover, 
PDMS makes it possible to reproduce features in the micron scale with high fidelity and 
is easy to process. (16; 17; 18; 19; 20; 21; 22; 23; 24)  
Despite all the interesting properties, PDMS presents also some drawbacks. 
The major limitations of PDMS are its hydrophobic nature, which makes the 
transferring and spreading of aqueous solutions difficult and may lead to complications 
in cell culture, as well as its low adhesiveness for cell attachment. (19; 20; 24) 
Moreover, PDMS may present large residual deformations (18), which can difficult its 
application in the micromachining field. Although being widely used as an implant 
material, PDMS leads to intermittent local and systemic adverse immunological effects, 
which includes the formation of a fibrotic capsule around the implant that can result in 
contraction causing severe pain and local tissue damage. (21)  
2.3. Applications 
Silicone biomaterials are used in several areas, due to its attractive properties. 
Some of the applications (Table 2) where silicone can be used are vascular grafts, 
urinary and intravenous catheters, heart valves, artificial joints, breast implants, contact 
lenses, voice prostheses, oxygenators, finger joints, artificial skin, among others. (3; 13; 
10) 
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Table 2. Applications of silicone biomaterials in the biomedical field. [Adapted from (3)] 
Application Examples 
Implants  Retinal tamponade; 
 Gel swelling agents. 
Lubricants  Silicone valves; 
 Syringes; 
 Needles; 
 Condoms. 
Soft tissue implant fillers  Brest implants; 
 Testicular implants. 
Membranes  Blood oxygenators; 
 Dialysis. 
Encapsulants  Cochlear implants; 
 Pacemakers/Defibrillators. 
Plastic surgery  Soft tissue implant envelopes; 
 Tissue expanders; 
 Maxillofacial implants.  
Ophthalmology  Punctum plugs; 
 Intraocular lenses. 
Urology  Penile implants; 
 Incontinence devices. 
Cardiology  Artificial heart valves. 
PDMS itself found its way in several applications, like numerous active and 
passive implantation devices, microfluidic devices (separations systems, micromixers, 
micropumps), microreactors, hydrophobic vent valves, microdevices for cell-culture, 
cell-based assays, DNA hybridization assays, among others. (16; 17; 18; 19; 20; 21; 
25; 26) 
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 3. Surface Modification 
Polymer surfaces are the boundaries between the bulk polymer and the 
surrounding environment. It is the surface that is responsible for the interaction of the 
polymer with the outer environment. Polymer surfaces are usually hydrophobic and 
chemically inert, which can lead to undesirable protein adsorption and cell adhesion. In 
order to overcome this problem, a great amount of research has been carried out in 
order to develop proper surface modifications of polymeric materials. (27)  
As previously mentioned, PDMS has been widely used in biomedical 
applications although this polymer also presents some drawbacks. (28)  Hydrophobicity 
is usually the main drawback, which can compromise its use in several medical devices 
(catheters, vascular grafts). The hydrophobic character of PDMS surface enhances the 
adsorption of numerous proteins, which can lead to microbial adhesion and, lately, to 
biofilm formation, and causes a lack of interaction between the device and the tissues. 
(28; 29) 
 To overcome the problems caused by the hydrophobic character of PDMS 
surface, the surface energy has to be increased in order to increase the hydrophilicity, 
and consequently PDMS surface functionality. Increasing the hydrophilic character of 
the surface, with no influence in the bulk properties of PDMS, can be achieved with 
surface modification techniques. (28) For the PDMS surface modification different 
treatments may be used, namely chemical, physical and a combination of both. (27) 
3.1. Physical Treatments 
 The physical modification of a polymer surface can be achieved in two different 
ways, one that involves the chemical modification of the surface layer and the other 
that involves the deposition of an external layer on top of the material surface. In the 
first case the physical techniques require the generation of high-energy species on the 
surface, like radicals, ions or molecules in the excited electronic state. In the second 
case it requires the deposition of atoms or atomic clusters coatings on the polymer 
surface. (28)  
There are several physical techniques, including sputtering and flame, corona, 
cold and hot plasma, ultraviolet (UV), laser, electron-beam and ion-beam treatments. 
Some of these techniques were already used to modify the PDMS surface, but the 
most used ones are corona, plasma and laser treatments. (28) 
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 Plasma Treatment 
Plasma treatment is the most common technique used to modify the 
hydrophobic character of a surface. This simple treatment leads to modifications that 
depend on the characteristics of the created plasma and on the system used. (29) 
 When a surface is modified with a plasma technique, depending on the gas that 
is used, the treatment can introduce groups in the surface or can activate the surface, 
which will make possible the linkage of water soluble polymers afterwards. (29) 
There are two types of gases that can be used in the plasma treatment, reactive 
gases and inert gases. When a reactive gas is used, the reaction that occurs between 
the polymer surface and the activated gas will lead to the surface modification. On the 
other hand, if an inert gas is used, free radicals are formed in the polymer surface. (30) 
Owen et al, in 1994, modified the PDMS surface with a plasma treatment. This 
group reported an increase in the wettability of PDMS surface. Several gases like 
argon, helium, oxygen and nitrogen were used, and a thin silica like layer was 
produced in the PDMS surface with all the gases. However, the surface modification is 
reversible. The surface rapidly recovers its hydrophobic character, which can be 
explained with the reorientation of surface silanol groups into the bulk polymer making 
possible the movement of free PDMS chains to the surface. (23; 29; 31) 
3.2. Chemical Treatments 
The chemical modification of a polymeric surface can be done in two different 
ways, a modification achieved by the direct chemical reaction with a solution (wet 
treatment) or a modification by covalent binding of macromolecular chains to the 
surface (grafting). Among different techniques the one most widely used is the surface 
grafting.  
Besides the surface grafting, other techniques can be used to achieve a 
chemical modification of the polymer surface. Some of these techniques include 
surface oxidation, etching, hydrolysis and functionalization. (28) 
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Surface Grafting 
 Depending on the polymer, different grafting techniques can be chosen to 
modify its surface (Figure 2). If the polymer surface presents suitable functional groups, 
an option is to attach large macromolecules to the appropriate surface (grafting on). 
The other option is to exploit these functional groups as possible sites to start the 
polymerization of a monomer (grafting from). (28; 32)  
 
Figure 2. Surface grafting of a generic surface. On the top figure it is possible to observe a 
representation of the grafting on approach. In the bottom the grafting from approach is 
represented. [Taken from (33)] 
The grafting from approach (Figure 2: bottom) presents several advantages 
when compared to the grafting on (Figure 2: top). Although the grafting on approach 
offers better define and characterized structures in the surface (the structures can be 
isolated and purified before being grafted), the grafting from approach has reduced 
preparative steps (the macromolecular material to be grafted doesn’t need to be 
prepared and isolated) and the surface density is not influenced by the dimension and 
mutual sterical constraints of the grafting material (the surface density depends on the 
density of the initiation groups). (32) Nevertheless, the formation of islands or 
mushrooms on the grafted on surface is often observed. (33) 
 Additionally, if the polymer has no chemically-reactive functional groups in its 
surface that allows the grafting initiation, it is possible to create radicals in the surface 
by chemical treatments followed by an initiation reaction or by irradiation. The 
irradiation can be carried out in the presence of a monomer (simultaneous irradiation) 
or the monomer can be added after the irradiation (pre-irradiation). (28) 
 Grafting modification that is induced by radiation is an extremely promising 
method for surface modification and can be used in most of the polymers that are 
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known. This technique enables the development of materials with new properties, since 
it allows to change the nature, morphology and structure of the modifying polymer and 
to control the thickness of the grafted layer. (28) 
 Several radiation sources have been used, with corona, plasma or glow-
discharge being the most common. When the radiation source is chosen, there are 
some factors to be considered, as the availability, the impact on the modification 
process and the penetration depth. (28) 
Among the grafting from techniques, atom transfer radical polymerization 
(ATRP) has been widely used and discussed, being a promising technique. It can be 
performed in mild conditions (room temperature in aqueous solution) and can be used 
in a wide range of polymers. In addition, this technique has negligible transfer 
reactions, due to the presence of monomers only in the end of the growing chains. (32)  
Atom Transfer Radical Polymerization (ATRP) 
Atom transfer radical polymerization (ATRP), which consists in a catalyzed 
reversible redox process, is one of the techniques used to carry out a controlled/living 
radical polymerization. (34; 35) This technique is easy to apply and makes possible the 
use of different monomers and reaction media (aqueous or organic) (36; 37) The 
monomers that may be used are styrenes, methacrylates (e.g. polyethylene glycol 
methyl methacrylate (PEGMA) and poly(2-hydroxyethyl methacrylate) (PHEMA)), 
methacrilamides, methacrylic acids and 4-vinylpyridine. (35) Furthermore, this 
technique allows to obtain polymer chains with controlled molecular weights and low 
poly-dispersity. (34) ATRP is also a suitable technique for growing polymeric brushes 
on surfaces. (37)  
 The name of the technique is based in the fact that both the activation and the 
deactivation of the radicals involve an atom transfer reaction. Being a radical 
polymerization process, this technique has four main steps: initiation, propagation, 
transfer and termination.  
 The initiation step consists in the formation of a reactive site, thus initiating the 
polymerization. After the initiation, the propagation step begins, with the monomers 
being added one by one to the active chain end. During the reaction, the active site can 
be transferred to the monomer, the initiator, the polymer or the solvent itself, in the 
transfer step. This step may result in the terminated molecule or in some new active 
site where the propagation may occur. The final step is the termination, which results in 
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inert macromolecules. This may occur by coupling reactions of two active centers or 
active transfer between active chains. (33) 
 All of these steps may be found in the ATRP process, as represented in Figure 
3. First the initiator covers the polymer surface. Many commercially available initiators 
(e.g. alkyl halides) can be used, as long as they present a weak halogen-heteroatom 
bond. The initiator will provide the polymer a surface with simple halogen as end 
groups, which is easily converted into useful functionalities. The transition metal 
complexes used (Ru, Cu, Fe, Ni, among others) are responsible for the conversation 
into useful functionalities, removing the halides from the polymer surface. The surface 
is then ready to a polymerization. (35) 
 
Figure 3. Schematic representation of the ATRP process. After the initiator (X) covers the polymer 
surface (R), the transition metal complex (Met) will remove the halides from the polymer surface. 
The monomer (M) will then interact with the polymer surface and the propagation of the monomers 
begins, culminating with the formation of polymeric chains in the polymer surface. [Taken from 
(33)] 
In order to achieve a controlled polymerization of the monomers, the initiation 
process has to be fast enough to provide a constant concentration of growing polymer 
chains, and there has to be a dynamic equilibrium between the inactive chains and the 
growing radicals. (38)  
 Xiao et al (2002) used ATRP to modify the PDMS surface. They used 
polyacrylamide chains to increase the hydrophilicity of PDMS. The amount of 
polyacrylamide reached a maximum after 15 min. However, after 30 min of exposure 
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visual inspection revealed PDMS damage. It was also observed that the treatment 
could be performed optimally before the occurrence of bulk damage. The surface 
became hydrophilic and, unlike the plasma treatment, the hydrophilic character of the 
modified PDMS lasted for at least one month. (39)  
3.3. Coating Materials 
Several materials have been used in order to increase PDMS surface 
hydrophilicity. Among these materials it is possible to find polymers and biomolecules. 
(28; 29; 37; 39; 40) Some polymers that are widely used in order to increase the 
hydrophilicity are the poly(ethylene oxide) (PEO), the poly(ethylene glycol) (PEG), the 
polyacrylamides (PAAm), among others.  
 PEG and its derivates have been used to change the hydrophilicity and the 
biomolecule-repelling properties of PDMS surfaces. This polymer is frequently used 
due to its low toxicity, low immunogenicity, and its ability to prevent protein, cell, and 
bacteria adhesion. However, PEG has only two hydroxyl groups available per chain, 
because of its linear structure. This can lead to some limitations in the surface 
modification. (37; 41)  
 PEO is structurally similar to PEG, but has a higher molecular weight. The 
surface coating with this polymer usually results in the reduction of biomolecules 
adsorption (e.g. proteins and bacteria). PEGMA, which is also used as a coating 
material, has a similar structure and similar properties. (37)  
 Other solution may be the use of the hydrophobic nature of PDMS and 
immobilize blood proteins on its surface. Because of the hydrophobic interaction, the 
proteins would bond and stay on the surface and remain part of the fluid that is washed 
off. (42) Some extracellular matrix (ECM) proteins (collagen, laminin, fibronectin) may 
also be used as a coating, promoting cell adhesion and migration. (40) 
3.4. Vascular Grafts Modification 
Vascular grafts have drawn high interest in the medical society, with the 
increased need of regeneration of vascular tissues. One of the most common materials 
utilized in vascular grafts is ePTFE. (43) Although this material presents interesting 
properties, some graft failure has been observed, due to thrombosis and intimal 
occlusion of the vessel. In order to avoid these limitations, an increased effort to seed 
the vascular grafts has been performed by several researchers. (44) 
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 Cezeaux and co-workers (1998) modified the surface of ePTFE using vacuum 
ultraviolet, with the purpose of increasing the endothelial cell adhesion. The modified 
surfaces could not increase endothelial cell adhesion, however the surfaces yielded an 
increased cell proliferation. These results suggest that the vacuum ultraviolet surface 
modification can be used to obtain more suitable surfaces for endothelial cell 
colonization of ePTFE vascular grafts. (44)  
 Adali et al (2010) reported a new approach for the cell seeding of grafts, namely 
the in situ endothelialization of implanted grafts inside the body. For that purpose, the 
endothelial progenitor cells (EPCs), which consist in a small population of CD34+ 
circulating mononuclear cells capable of attaining endothelial cell characteristics in 
vitro, are the best candidates. The limitation of using such cells for in situ 
endothelialization of grafts is due to the fact that these cells are mainly located in the 
bone marrow and only small amounts of EPCs circulate in the blood. Thus, these cells 
need to be mobilized to the implant site and seed their surface. The proposed strategy 
is coating the graft with capture molecules that attract the circulating EPCs and 
increase their adhesion to the surface. (4)  
 Furthermore, Larsen et al (2006) synthesized a novel peptide fluoro-surfactant 
polymer modification that facilitates the adhesion and growth of endothelial cells on 
ePTFE vascular grafts. The peptide fluoro-surfactant polymer consists of a poly(vinyl 
amine) backbone with RGD sequences and perfluorocarbon pendant branches. 
Endothelial cells showed a specific adhesion to the RGD sequences and retained an 
hemostatic function. (45)  
4. Body-Biomaterial Interactions 
Replacing injured tissues with biomedical devices is currently the main 
approach in biomaterials science, because substitutes of biological origin are 
recognized by the immune system. This happens due to the presence of biological 
motifs in this substitutes that are immunologically recognizable. (2) 
 Once the biomaterials are intended to contact directly with living tissues and 
biological fluids, they are targets for the protective mechanisms within the body (protein 
adsorption, hemostasis, inflammation, foreign body response). During the past decade 
it was recognized that all implantable biomaterials invoke an almost identical 
inflammatory and foreign body response, despite the biomaterial nature. Currently 
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obstacles related to the design of biomaterials involve the interaction of biomaterials 
with the body and the reaction of the body to biomaterials. (46)  
Therefore, understanding and predicting the interaction between tissues or body 
fluids with biomaterials is crucial to all kinds of medical technologies. The 
reconstructive medical implants require a perfect integration of the biomaterial with the 
surrounding tissues to restore adequate function, with no release of harmful products. 
(2)  
4.1. Cell-Biomaterial Interaction 
 Cell adhesion to biomaterials surface is a critical step in the integration of 
implants. Therefore, the interaction of cells with biomaterials is an important feature of 
in vitro biocompatibility and cytotoxicity studies. This adhesion is mediated by adsorbed 
proteins, like immunoglobulins, vitronectin, fibrinogen and fibronectin. (47; 48)  
 The main parameters of cell-biomaterial interactions are the cell adhesion and 
the cell spreading. Cell adhesion and spreading are the consequence of a series of 
molecular events (Figure 4) that occur in and around the cells, which are mediated by 
the trans-membrane receptors present in the extracellular matrix (ECM). (49)  
 
Figure 4.  Progression of the mammalian cell adhesion. (A) Initial contact of the cell with the 
material covered by proteins. (B) Formation of bonds between the cell surface receptors and the 
cell adhesion ligands in the proteins. (C) Cytoskeletal reorganization with a progressive spreading 
of the cell in the surface of the implant, increasing the attachment strength. [Taken from (1)]    
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4.1.1. Extracellular Matrix (ECM) 
The ECM is secreted by the cells that populate a tissue or organ. Its 
composition will be determined by factors like the mechanical forces, the oxygen 
requirements, the gene expression patterns. This matrix plays a crucial role in the 
mammalian development and physiology, and both the amino acid sequence and the 
quaternary components of the ECM are greatly preserved across species lines. (49)  
 The composition of the ECM is a mixture of functional and structural proteins 
(collagen, fibronectin), glycosaminoglycans (GAGs), glycoproteins and small molecules 
(figure 5). All this components are arranged in a unique three-dimensional architecture. 
(49) 
 
Figure 5. Cell proteins involved in cell adhesion on a biomaterial. [Taken from (50)] 
Collagen 
 Collagens represent more than 90% of the dry weight of the ECM, being the 
most abundant proteins in the mammalian ECM. More than 20 different types of 
collagen where identified and the type I collagen is the major structural protein in 
tissues. Type I collagen is abundant in tendinous and ligamentous structures, providing 
the necessary strength that these tissues require. Other types of collagens can be 
found in the ECM in much lower amounts than the type I collagen, although providing 
different mechanical and physical properties to the ECM. One example is the type IV 
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collagen, which is present within the basement membrane of most vascular structures 
and tissues with an epithelial cell component. (49)  
Fibronectin 
Fibronectin is the second most abundant protein in the ECM. It is a large 
dimeric glycoprotein that exists either in the soluble state or as a tissue isoform. This 
protein is a mediator of mammalian cells adhesion, because it possesses ligands for 
adhesion of several cell types. Fibronectin is rich in the tripeptide Arg-Gly-Asp (RGD), 
which is recognized by the cell surface receptors, the integrins, thus being extremely 
important in cell adhesion. When bound via integrins, these proteins trigger a number 
of signal transduction pathways that activate events like cell spreading, proliferation, 
differentiation and migration. This protein is critical for normal biologic development, 
especially the development of vascular structures. (49; 51)  
Laminin 
Laminin is an adhesion protein present in ECM that exists in numerous forms, 
depending in the specific mixture of the several peptide chains. It is determinant in the 
formation and maintenance of vascular structures. This protein is one of the most 
critical ECM factors in the process of cell and tissue differentiation. (49)  
Glycosaminoglycans 
It is possible to find several mixtures of GAGs in the ECM, depending on the 
tissue location, the age of the host and the microenvironment. The GAGs have various 
functions, like binding growth factors and cytokines, promoting water retention and 
contributing to gel properties of the matrix. Heparin and hyaluronic acid are two GAGs 
present in the ECM. (49) 
Growth Factors 
Growth factors and cytokines, although in small amounts, are also present in 
the ECM. However, they act as potent modulators of cell behavior. There is an 
extensive list of growth factors present in the ECM, including the vascular endothelial 
cell growth factor (VEGF), the fibroblast growth factor (FGF) family, and the epithelial 
cell growth factor (EGF), among others. These factors can be found in different 
isoforms, each with a specific biologic activity. (49)  
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4.1.2. Adhesion Molecules - Integrins 
 The adhesion molecules include four main classes – selectins, immunoglobulin 
super family, adhesins and integrins- and are capable of interacting with specific 
ligands situated on the membrane of neighbor cells or on the ECM. (50)  
Among the four classes of adhesion molecules, the integrins are the main cell 
surface receptors for proteins within the ECM. (52) The integrin family is composed of 
22 heterodimers with two types of subunits, α and β, that are non-covalently 
associated. There have been discovered 16 α subunits and 8 β subunits, that 
combined in different ways can origin a diversity of structures with various ligand-
binding possibilities. In the integrin structure, each subunit has a large extracellular 
domain, a transmembrane domain and a short cytoplasmic domain. (48; 50; 52; 53; 54; 
55)  
 Integrins can bind to specific amino acid sequences, such as the RGD motif 
that is present in many ECM proteins. (49; 53; 54) Besides the ECM proteins, integrins 
can interact with components of the cytoskeleton and signaling molecules through their 
intracellular domain. Being an interface between the extracellular and the intracellular 
environment, integrins can translate the attachment of external ligands to internal 
information, inducing adhesion, spreading, cell migration and cell growth and 
differentiation. (50)  
 After binding specifically to a ligand, the integrins cluster together into focal 
adhesions. Focal adhesions consist of additional cytoskeletal proteins, adapter 
molecules and kinases, being an area of close contact between the cell and the ECM. 
The integrins are present in these areas in higher amount than their normal membrane 
distribution. Focal adhesions are barely formed on hydrophobic surfaces, and well 
developed in surfaces that sustain cell adhesion. (53; 54)  
 When clustered, the recruitment of tensin and focal adhesion kinase (FAK), as 
well as their phophorylation start, resulting in the recruitment of talin, vinculin and α-
actinin, which are responsible to link the F-actin fibers to the plasma membrane. The 
rearrangement of F-actin fibers induces changes in the organization of the cytoskeleton 
(and consequently in the cell shape), affecting cell adhesion and mobility. (53; 54)  
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4.2. Adhesion Proteins  
When a biomaterial is implanted, in a question of seconds to minutes, a layer of 
proteins rapidly adsorbs and covers its surface. (47; 56) Therefore, instead of the 
original surface of the implanted material, the cells will recognize this protein layer. It is 
possible to say that the adhesion proteins convert the biomaterials into a biologically 
recognizable material. The adsorption of these adhesion proteins is the basis for all the 
reactions that may occur in the body. (1)  
 
Figure 6. Surface placed in a protein mixture. In a matter of seconds the surface is covered by a 
layer of adsorbed proteins. Initially, the “red” and the “green” proteins adsorb in a higher 
concentration. With time, these proteins are displaced by the “blue” protein. This can happen 
because the concentration of proteins in the adsorbed layer is usually different from the 
concentration in the solution, being able to change in time. [Taken from (47)] 
The surface properties of the biomaterials (chemistry and hydrophobicity) 
determine the type, amount and conformation of the adsorbed proteins. The 
composition of this protein layer can be different, depending of the fluid composition 
and adsorption time. In figure 6 it is possible to observe that initially the “red” and the 
“green” proteins are present in a higher concentration, but with time these proteins are 
displaced by the “blue” proteins. Besides the composition of the protein layer, the 
conformation and the orientation of the protein can also change with time, as 
represented in figure 7 (44,54).  
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Figure 7. The top scheme shows a protein denaturing with increasing adsorption time. The bottom 
scheme shows a proteins adsorbing to the surface in different orientations. This is possible 
because the conformation and the orientation of adsorbed proteins depend on adsorption 
conditions and surface properties. [Taken from (47)] 
The layer of proteins that is formed will increase the cell adhesiveness, since 
the cells have receptors in the cell membrane, which bind specifically to the adhesion 
proteins. This layer of adhesion proteins also increases the cell spreading in the 
surface. 
4.3. Host Immune Response 
Nowadays it is known that there are no inert biomaterials. The medical implants, 
being foreign to the host body, will trigger tissue responses during the healing process 
that are dependent on the nature of the biomaterial and the implant site. (57) Indeed, 
the host-biomaterial interaction is a very complex process that will control the biological 
performance of the medical implants. (56)  
When the biomaterial is implanted in the body a wound is created and a series 
of events, initially similar to the ones in normal wound healing, will occur. The process 
of implantation disturbs the homeostatic mechanism in the body, thus activating the 
healing process. (58)  
The way the implant is accepted by the host and how well the host will heal 
depends largely on the way the complex wound healing around the device will occur. 
The wound healing process includes four phases, namely the inflammation, the foreign 
body reaction, the fibrous encapsulation and the matrix formation and remodeling. (57; 
58)  
 The host body reacts similarly to nearly all the biomaterials, as represented in 
figure 8. After one month of implantation, all the biomaterials are found to heal basically 
in the same way.  
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Figure 8. Reaction of the host to the implanted biomaterial. (1) The biomaterial is implanted in the 
surgical site by the surgeon. (2) A layer of proteins quickly adsorbs to the implant surface. (3) The 
neutrophils and the macrophages examine and attack the biomaterial. However the implant is too 
large to be ingested. (4) The macrophages find that they cannot digest the implant, so they fuse 
into giant cells to engulf the implant. The giant cells send out cytokines to attract other cells. (5) 
The fibroblasts arrive and start synthesizing collagen. (6) The implant is completely entrapped in 
an acellular, avascular collagen bag. [Taken from (47)] 
The inflammation process can be trigged by surgery trauma or the presence of 
a foreign body in the host. In the 24 hours after the surgery cellular and non cellular 
responses will take place. The first event is a non cellular response, the vasodilatation 
of the local vessels, which culminates with the increased permeability of the vascular 
endothelium and the edema formation. In parallel the complement cascade is activated 
by the membrane damage. Then the cellular response also takes place with cell 
recruitment. (59) Several molecular signals will act as chemoattractants at the implant 
site, recruiting the inflammatory cells. (58) 
The first cells migrating to the injury site are the neutrophils, which are 
responsible for the phagocytosis, the engulfing and the degradation of the foreign body. 
Once neutrophils start their function, the monocytes circulating in the blood enter the 
tissue and become macrophages, which are also responsible for the phagocytosis and 
release several biochemical factors that can activate other cells. (59) The activated 
macrophages adhere to the material and spread on its surface, trying to phagocyte it. 
Because they cannot digest or engulf the implant, they fuse together and origin a 
foreign body giant cell, which can phagocytize larger particles. It is the presence of the 
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foreign body giant cells long after the implantation that indicates the existence of a 
chronic inflammation. (47)  
 The foreign body giant cells are still not capable of engulfing the implant, so 
they signal the host body for the presence of this large mass that needs to be walled 
off. Then the fibroblasts arrive and generate the collagen capsule. (47)  
In the end of the inflammatory response, the tissue remodeling starts. First, the 
dead cells are phagocytized and removed, then granulation and neovascularization 
take place. The provisional matrix is dissolved and it´s replaced for a mature and 
functional matrix, which provides a biomechanical scaffold for cell attachment and 
anchorage of macromolecules. It is when the provisional matrix starts to disappear that 
the deposition and remodeling of collagens determine the healing capacity of the 
wound. (57; 59) 
There are two types of factors that can influence the wound healing process, 
the intrinsic factors and the extrinsic factors. The bulk nature of the material, its 
porosity, roughness and changes in the surface chemistry are intrinsic factors of the 
implant. The extrinsic factors are, for example, the surgical procedure, the condition of 
the patient (diabetic, immunocompromised) and the anatomical location of the implant. 
(57)  
The end of the inflammation process is characterized by the scar maturation, 
with the type III collagen being replaced by type I collagen. The type I collagen is 
stronger and less elastic, allowing the wound to gain tensile strength, which results in a 
dense and fibrous tissue. (59)  
Besides this universal immune response that is only slightly affected by the 
structure and chemical composition of the foreign material, there can be a more 
specific immune response. This response is determined by a humoral response, 
characterized by the production of freely circulating antibodies mediated by B 
lymphocytes, and a cell mediated response, carried out by the T lymphocytes. The 
immune system is responsible for triggering the inflammatory response to foreign 
tissues that can culminate with rejection, but this system can adapt and develop a 
specific memory to a specific foreign material, resulting in a hypersensibility or allergy 
to that material. (59) 
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Chapter 2. Materials & Methods 
 In the current work, modified silicone rubber surfaces have been evaluated 
regarding their interaction with mammalian cells under culture conditions (in vitro). Two 
cell lines were used as model cell lines to assess the effect of the PDMS surface 
modification on cell adhesion, namely human skin fibroblasts (HSkF) and human 
umbilical veins endothelial cells (HUVECs). Silicone surfaces modified by atom transfer 
radical polymerization (ATRP) (Figure 9) under the scope of the BIOSURFA project 
were kindly provided by the Department of Biological Engineering, University of Minho, 
Portugal.  
 
Figure 9. Representation of poly(ethylene glycol) methyl methacrylate (PEGMA) polymer brushes 
formed in the PDMS surface due to the ATRP modification. [Taken from (60)] 
 The surface modification process starts with the surface activation. In this step, 
both PDMS (Stockwell Elastomerics, Inc.) surfaces (top and bottom) were exposed 
during 10 min to UV radiation and for 30 min to Ozone. Then, a 94% solution of the 
initiator (1-Trichlorosilyl-2-(P,M-Chloromethylphenyl)Ethane(94%)) was evaporated 
under vacuum, in order to have a chemical vapor deposition of the initiator onto the 
PDMS surfaces. After washing and drying the PDMS samples, they were polymerized 
with PEGMA using the following monomer and catalysts: [PEGMA]:[CuII]:[CuI]:[bpy] 
(PEGMA: Copper II: Copper I: 2,2'-Bipyridine) in the molar proportions of 22:1:0,2:2. 
The samples were washed and dried again in order to obtain the final modified PDMS 
surfaces. 
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1. Surface Modification 
The PDMS surfaces, which were modified by ATRP at University of Minho, 
were coated with a layer of fibronectin and a layer of gelatin before cell culturing, to 
achieve a higher cell adhesion. 
1.1. Fibronectin Coating 
 Fibronectin (Sigma F2006) was stored in vials at -20°C in a concentration of 1 
mg per ml of PBS. For the coating, a 5 μg/ml concentration was used. Next, 750 μl of 
fibronectin solution was added to each well and the plate was incubated for 30 min at 
room temperature. After that, the solution was removed and the cells were added 
according to the procedure described in section 4.1. 
1.2. Gelatin Layer 
For the HUVEC cells experiments, after placing the PDMS sample, 1 ml of 
gelatin was added per well. The plate was incubated for 30 min at 37°C, in the CO2 
incubator. After the 30 min, the gelatin was discarded and the cells were added 
according to the procedure described in section 4.1. 
2. Surface Characterization  
2.1. Contact Angles 
 The material used in the current work was the modified silicone rubber surfaces 
abovementioned, in which it is expected to encounter PEGMA brushes. One way to 
evaluate the presence of these brushes at the surface is through the determination of 
its hydropobicity/hydrophilicity. Therefore, contact angles of the modified and 
unmodified PDMS were measured using the Spindler&Hoyer contact angle meter and 
the Novell software ContactAngle.  
A contact angle can be measured by adding a drop of liquid to a solid surface. 
The contact angle is an indication of the surface hydrophilicity/hydrophobicity since it 
measures how much a droplet spreads on a given surface. Using a water droplet 
(Figure 10), the more hydrophilic the surface is the lower the contact angle will be. On 
the other hand, higher contact angle values represent more hydrophobic surfaces. 
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Figure 10. Water drops formed in the surface. Contact angle between the water drop and the 
surface depends on the surface hydrophobic/hydrophilic character. [Taken from (61)]. 
 
The contact angle was measured at room temperature, using the sessile-drop 
method with water. For the modified PDMS, the contact angle was measured in 5 
different surfaces (5 replicates). On the contrary, for the unmodified PDMS the contact 
angles were measured in 2 replicates. Three droplets were measured per sample. 
2.2. Atomic Force Microscopy (AFM) 
Surface topography can be studied by AFM (atomic force microscopy). (62) 
Using this technique it is possible to probe surface roughness and assess if the 
PEGMA coating was uniform.  AFM was used to determine if the fibronectin coating 
was successfully accomplished.   
 The image acquisition by AFM results from a tip attached to a flexible cantilever 
moving across the sample surface. This will make possible to assess the surface 
morphology on an atomic scale, by detecting changes in the surface height from 
measuring the location of the reflected laser beam in the quadrant photodetector. The 
result is a surface topographical map from which surface roughness values can be 
determined. (61)  
The AFM (Dimizion 3100, Bruker) was used in the contact mode, at room 
temperature in air with a Bruker np tip, to characterize the modified PDMS surfaces. 
The software used was the NanoScope IVa Controller. Measurements (3 
measurements per sample) were conducted on two modified PDMS surfaces. After 
fibronectin was adsorbed to these surfaces, they were again analyzed in AFM. The 
surfaces were then seeded in a ratio of 6.7x104 cells per well and incubated (5% CO2, 
37ºC) for 24 h. Then, the medium was removed and the cells were incubated with 
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distilled water until all the cells detached from the surface. Afterwards the surfaces 
were observed by AFM. 
3. Surface Cytotoxicity  
 To evaluate if some toxic substances could be released from the modified 
PDMS samples a cytotoxicity assay was conducted (Figure 11). Two modified PDMS 
samples were cut into 4 squares of 1 cm2 and one of the samples (4 squares) was 
subjected to a washing procedure.  
 
Figure 11. Scheme of the cytotoxicity assessment experiment. First, samples were cut into 4 small 
squares (1 cm
2
). One of the samples was washed and the other was only sterilized. The 4 squares 
of each sample were placed in a 12 well-plate and the cells were seeded. 
In the washing procedure, the 4 squares of one sample were placed in a 50 ml 
falcon with distilled water for 30 min under agitation. Next, the squares were moved 
into another 50 ml falcon with ultra-pure water for 30 min under agitation. Finally, the 
samples were placed in a new 50 ml falcon with 70% ethanol for 30 min under 
agitation. The non-washed sample was sterilized with 70% ethanol. Then, the squares 
of both samples were sterilized by 5 min exposure to UV radiation (both sides of the 
sample) and placed in the wells of a 12 well-plate. Finally, 2 ml of culture medium were 
added to each well and the plates were incubated for 24 h (37°C, 5% CO2).  
 After 24 h the samples were placed in a new 12 well-plate, with 2 ml of fresh 
medium in each well, and were incubated for another 24 h (37°C, 5% CO2). The 
previous 12 well-plate was kept in the fridge. This step was repeated again in order to 
dilute the possible leachables twice. 
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Figure 12. Schematic representation of the 96 well-plate used to seed the cells. Cells were seeded 
in a concentration of 5 x 10
4
 cells/ml. After 24 h the medium was changed. Row A: medium 
incubated with the washed modified PDMS in the first 12 well-plate. Row B: medium incubated with 
the non-washed modified PDMS in the first 12 well-plate. Row C: medium incubated with the 
washed modified PDMS in the second 12 well-plate. Row D: medium incubated with the non-
washed modified PDMS in the second 12 well-plate. Row E: medium incubated with the washed 
modified PDMS in the third 12 well-plate. Row F: medium incubated with the non-washed modified 
PDMS in the third 12 well-plate. Row G: control with fresh medium. 
The cells were seeded in a 96 well-plate (Figure 12) in a concentration of 5 x 
104 cells/ml (for details on cell culture see section 4.1). Each well contained 100 μl of 
medium with cells, i.e. 5000 cells per well. The plates were incubated for 24 h (37°C, 
5% CO2). Next, the medium was removed and 100 μl of the medium with possible 
leachables were added to each well. The 96 well-plate was incubated for 24 h (37°C, 
5% CO2). 
In order to improve the cytotoxicity assessment and to obtain more conclusive 
results, some modifications have been introduced to the procedure described before. 
Modified PDMS samples were cut, washed and sterilized prior to the experiment. 
Afterwards, PDMS samples were placed into a 12 well-plate with 1 mL of culture 
medium and incubated for 72 h (37°C, 5% CO2). After the referred incubation time, the 
culture medium was diluted according to the following ratios: 1:2, 1:4 and 1:8. Cells 
were seeded in a 96-well tissue plate and incubated for 24 h (37ºC, 5% CO2). Next, the 
medium was replaced by the one that has previously been in contact with the samples, 
both diluted and undiluted, and cells were left to incubate for 72 h.  
 To measure the percentage of metabolically active cells and the percentage of 
viable cells in each well, after the incubation period the MTT and crystal violet (CV) 
assays were performed (for details see sections 2.4.1 and 2.4.2). The percentage of 
metabolically active viable cell was calculated dividing the two values. 
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3.1. MTT Assay 
MTT (“3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyl‐tetrazolium bromide) is a 
tetrazolium salt that has been widely used in order to screen the biochemical activity of 
cell cultures. Cells are capable of reducing this salt in their mitochondria, resulting in a 
formazan precipitate that can be dissolved with n-propanol and quantified 
spectrophotometrically. (48) 
 First, the medium of the 96 well-plates was discarded, the wells were washed 
with 1 ml of sterile PBS (37ºC) and 100 μl of MTT (Sigma) in a concentration of 0.5 
mg/ml (diluted in culture medium) were added to the wells. The plate was incubated 
(37°C, 5% CO2) during 2 h. After checking for cellular changes in coverage and 
morphology, the medium with MTT was gently removed and the wells were washed 
with 1 ml PBS (37ºC). Once the wells were again washed with PBS (37ºC), 120 μl of 2-
propanol were added to each well and the plates were put on the orbital shaker at high 
speed (1100 rpm) until the formazan was completely dissolved. The absorbance was 
then measured at 570 nm in an automated plate reader (FluoStar Optima). 
3.2. Crystal Violet (CV) Assay  
 Following the MTT determination, the same test plate with cells was washed 3 
times with a PBS plus 0.05% Tween 20 solution. Then, 50 μl of 0.1% crystal violet 
(Sigma) solution were added to each well and the plate was incubated for 20 min at 
room temperature while shaking. After that, the plate was washed 4 times with running 
tap water. The cell-bound stain was extracted with 33% acetic acid (100 μl per well) 
while shaking for 15 min. The supernatant was transferred to a new 96 well-plate and 
the optical density was measured at 560 nm. 
4. Cell-Biomaterial Interaction 
4.1. Cell Culture 
The human skin fibroblasts (HSkF) used in the experiment belong to the ATCC 
(American type culture collection) collection CRL-2429 (cell line CCD 1112SK). The 
human umbilical veins endothelial cells (HUVECs) were provided from the Department 
of Medical Biology of the University Medical Centre of Groningen. The medium used for 
the HSkF was the RPMI (Roswell Park Memorial Institute) complete (Gibco, UK), 
composed of 90% of RPMI medium (Gibco), 10% of fetal bovine serum (FBS, Gibco 
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10099‐141, UK), 1% of penicillin‐streptomycin (Gibco 15140‐122, UK) and 1 % of 
L‐alanyl‐LGlutamine (GlutaMAX‐I, Gibco 35050‐038, UK). Regarding the HUVECs, the 
medium was supplied for the same department that kindly provided the cells. 
The HSkF were stored in vials that were immersed in liquid nitrogen. To thaw 
the HSkF, a vial was removed from the liquid nitrogen and transferred to a water bath 
(37°C) until an ice clump was floating in the vial. Then, the vial was immersed in a 70% 
ethanol solution (room temperature) for decontamination, cleaned with a Kleenex 
tissue and transferred to the laminar flow cabinet1 (Clean Air Techniek B.V., Woerden, 
Netherlands).  
Then, 20 ml of the culture medium previously warmed (37ºC) were transferred 
to a centrifuge tube. After opening very carefully the vial, its content was transferred 
into the warm medium and the solution was homogenized. The solution was then 
centrifuged for 5 min at 1200 rpm (Heraeus Labofuge 400R centrifuge), the 
supernatant was discarded and the pellet was resuspended in 5 mL of fresh medium. 
This solution was transferred to a 25 cm2 tissue culture polystyrene flask (Greiner) and 
incubated in the CO2 incubator (Steri-Cycle, Thermo Forma, Marietta, Ohio, USA) at 
37°C, 5% carbon dioxide and humidity saturated atmosphere. 
The cells were kept in T-flasks until confluence was reached. Whenever 
confluence was reached, the cells were sub-cultured. The medium was removed from 
the flask and few milliliters of 1 % PBS (phosphate buffer saline; 137 mM NaCl, 1.47 
mM KH2PO4, 8.1 mM Na2HPO4, 2.68 mM KCl) solution were added to wash the flask 
and remove any remaining serum2. Afterwards, the PBS solution was discarded and 
trypsin/EDTA (ethylenediamine tetraacetic acid) 0.05% (Gibco, UK) was added. For a 
25 cm2 flask the recommended volume of trypsin is 1 ml and for a 75 cm2 flask is 3 ml. 
The cells were then incubated in the CO2 incubator during 2-15 min to allow cell 
detachment from the flask. The detachment time depends on several variables like the 
cell type, the enzyme added and the passage number. After cell detachment, 4 or 5 mL 
of culture medium were added to the cell suspension in the case of 25 cm2 or 75 cm2 
flask, respectively. The cell suspension was then transferred to a 50 ml falcon. 
Furthermore, to wash any remaining cells in the flasks, 2.5 or 5 ml culture medium 
were added to the 25 cm2 or the 75 cm2 flask, respectively, and transferred to the 50 ml 
                                                 
1 From this step forward, all the procedures are carried out in the laminar flow cabinet. 
2 Trypsin is inactivated by serum, so the flask has to be washed in order to remove any serum that may 
remain in the flask. 
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falcon. After determining the cell density in a Burker‐Turk counting chamber 
(0.0025mm2, Labor Optik) and dividing the cellular suspension into new culture flasks 
according to the optimal passage ratio, fresh culture medium was added to each flask 
so the total volume on the 25 cm2 or the 75 cm2 was 6.5 ml or 15 ml, respectively. The 
flasks were then incubated in the CO2 incubator at 37ºC in a 5% carbon dioxide and 
humidity saturated atmosphere. 
 4.1.1. Specific conditions 
 The HSkF were sub-cultured (when they reached 80% confluence), usually 
after 3 to 4 days, in 1:2 splitting ratios.   
 The HUVECs require a thin layer of gelatin (Sigma) to adhere, grow and reach 
confluence. The gelatin-coated culture flasks were pre-incubated in the CO2 incubator 
for 30 min, and afterwards the gelatin that was not solid was removed immediately 
before adding the cell suspension to the flask. During the cell sub-culturing some extra 
care was needed, like pipetting to the lateral side of the flasks, so that the gelatin layer 
was not disturbed.  These cells were subcultured after 3 to 4 days in 1:3 splitting ratios.   
4.2. Cell Interaction with Modified and Unmodified PDMS 
In order to evaluate the influence of the PEGMA coating in cell adhesion, both 
unmodified and modified PDMS surfaces were incubated with the cell lines above 
referred.   
The modified PDMS samples were cut in 1 cm2 squares, and then sterilized with 
70% ethanol and 5 min of UV radiation in both sides. Next, each square was placed in 
a well of a 12 well-plate. For the experiments conducted with fibroblasts, two 12 well-
plates were used since two different incubation times were tested. The first four wells 
contained the unmodified PDMS samples, the next four the modified PDMS samples, 
and the last four the modified PDMS samples with a fibronectin coating (Figure 13). 
The same setup was used for the HUVEC cells, but in this case an extra plate was 
used for each time, with four modified PDMS samples covered with a gelatin layer, in a 
total of four plates (Figure 14).  
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Figure 13. Distribution of PDMS samples in the 12 well-plate, for the experiments with HSkF. The 
first 4 wells contain unmodified PDMS surfaces, the next 4 contain modified PDMS surfaces and 
the last 4 wells contain modified PDMS with a fibronectin coating. The 12 well-plate was prepared 
in duplicate, one to be incubated for 48 h and the other for 120 h. 
 
 
Figure 14. Distribution of PDMS samples in the 12 well-plate, for the experiment with HUVECs. In 
the left plate, the first 4 wells contain unmodified PDMS surfaces, the next 4 contain modified 
PDMS surfaces and the last 4 wells contain modified PDMS with a fibronectin coating. In the 
second plate, the first 4 wells contain modified PDMS with a gelatin coating. Both the 12 well-plate 
were prepared in duplicate, one to be incubated for 48 h and the other for 120 h.  
The cells were seeded in the wells containing the PDMS samples in a ratio of 
6.7x104 cells per well. Afterwards, the plates were incubated (5% CO2, 37ºC) at two 
different time points, namely 48 and 120 h. After the 48 h, the cells of one plate were 
fixed using 0.9 ml of PFA (paraformaldehyde; 3.7% paraformaldehyde in CS buffer: 0.1 
M PIPES, 1 mM EGTA, 4% (w/v) polyethylene glycol 8000 (all Sigma), pH 6.9) during 5 
min. Then, extra 0.9 ml of PFA was added, this time for 10 min, and after removing the 
PFA, 1 ml of PBS was added. The plate was then wrapped up with aluminum foil and 
stored at 4ºC. The same procedure was carried out in the second plate, after the 120 h 
of incubation. Finally, cells in both plates were stained with fluorescent markers 
according to the procedure described in the “Immunocytochemistry Assay” section. 
After staining the samples were observed and pictures were taken with Confocal 
Microscopy.  
Based on the results obtained, the previously described experiment was 
repeated for the HUVECs, but using a different distribution of the samples (Figure 15). 
With this new sample distribution, it was possible to conclude about the surface 
influence in cell adhesion and proliferation since the only variable of the experiment 
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was the surfaces being used. The incubation times changed from 48 and 120 h (2 and 
5 days) to 3, 4 and 5 days. 
 
 
Figure 15. Distribution of PDMS samples in the 12 well-plate, for the second experiment with 
HUVECs. In the left plate, the first 4 wells contain unmodified PDMS surfaces with adsorbed 
fibronectin, the next 4 contain modified PDMS surfaces with adsorbed fibronectin and the last 4 
wells only contain a fibronectin coating. In the second plate, the first 4 wells have no additional 
surface or coating. Both the 12 well-plate were prepared in triplicate, one to be incubated for 3 
days, the other for 4 days and the last for 5 days. 
 
 4.2.1. Immunocytochemistry Assay 
 The immunocytochemistry assay was performed in 2 (out of 4) wells for each 
surface. After cells fixation, 1 mL of 5% BSA (bovine serum albumin; Sigma) in PBS 
was added to each well for 10-20 min to block non-specific background. Then, 750 μL 
of the primary antibody diluted in PBSA (PBS + 1% BSA) were added to each well for 1 
hour, at 20°C. Before incubating the secondary antibody each well was washed three 
times with 1 mL of PBSA. The secondary antibody, previously diluted in PBSA was 
incubated for 1-2 h at 20°C. Because of the fluorescent label the plates were covered 
up with aluminum foil during the incubation times. Afterwards, the wells were washed 4 
times for 5 min with 1 mL of PBSA and 2 times for 5 min with PBS. Then, the plates 
were again covered up with aluminum foil and were ready to be observed under 
Confocal Microscopy. 
 Two different first antibodies were used, a polyclonal rabbit-α-human fibronectin 
and a monoclonal mouse-α-human vinculin, in order to stain the fibronectin and the 
vinculin networks, respectively. Therefore, two second antibodies were used as well, a 
donkey-α-rabbit IgG (immunoglobulin) with a redX (rhodamine) fluorescent label and a 
goat-α-mouse IgG with a FTIC (fluorescein isothiocyanate) fluorescent label. In order to 
use these antibodies, adequate dilutions had to be performed. For the rabbit-α-human 
fibronectin a 1:400 dilution was used. For all the other antibodies, mouse-α-human 
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vinculin, donkey-α-rabbit IgG and goat-α-mouse IgG, the dilution ratio was 1:100. 
Finally, DAPI (4',6-diamidino-2-phenylindole) was also added to stain the nuclei of the 
cells (4 μg/mL), as was TRITC-labelled phalloidin (Sigma, 2 μg/mL).  
 4.2.2. Confocal Microscopy 
Cells were observed using a LEICA TCS SP2 (LEICA, Germany) confocal 
microscope. To observe the cells conformation and quantify the cell number and the 
expression of fibronectin and actin, the Leica Confocal Software (version 2.61) and 
ImageJ program (version 1.41) were used. Pictures were taken in three different places 
in each sample. Using the Leica Software, several confocal images stacks that 
correspond to several optical slices were taken. The thickness of each image stack 
was chosen with the purpose of including all the relevant structures. After that, it was 
possible to create a two dimensional projection, that is an overlay of all images of each 
sample. The scale and resolution were the same for all the pictures; therefore the 
results could be compared. The area of the pictures was of 375μm x 375μm and the 
number of pixels was of 1024 per 1024. 
 
Figure 16. Scheme representing the image processing for cell number quantification. (A) image 
stack (B) overlay image (C) selection of DAPI staining fluorescence (D) particle analysis image. 
[Taken from (60)] 
After the overlay image was obtained (Figure 16B), the DAPI staining 
fluorescent was selected (Figure 16C). Then, it was possible to count the number of 
nucleus and consequently quantify the cell density. For this purpose, Scion Image 
Software (version β 4.0.2) was used. After setting some parameters in the software it 
was possible to count the intact nuclei (Figure 16D). The same software was used to 
determine the percentage of fibronectin in each sample.    
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5. Statistics 
 The statistical analysis of the experiments was conducted using two methods, 
the t-test and the ANOVA. The t-test was used to compare the results obtained for 2 
different groups, considering a significance level (α) = 0.05. Whenever 3 or more 
different groups were compared, the ANOVA was used, also with an α = 0.05. 
Regarding the ANOVA statistical analysis, when 3 or more independent samples with 
only one variable (e.g. concentration) were compared the one-way ANOVA was 
performed. However, when two variables were present (e.g. time and concentration) 
the two-way ANOVA was required.  
Moreover, the ANOVA model only allows to state that 3 or more independent 
samples are statistically different. Using ANOVA it is not possible to determine which 
groups are different. Therefore, the t-test was used to compare the independent 
samples in groups of 2 (N=3, sample A was compared with sample B, after was 
compared with sample C, and finally sample B was compared with sample C). 
The two statistical methods used give a p-value (probability that the variance is 
not significant) from the F statistic. When the p-value is higher than α it can be 
concluded that the samples do not present significant statistical differences. On the 
other hand, if p < 0.05 the samples present significant statistical differences.  
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Chapter 3. Results & Discussion 
 
This chapter gathers the results obtained in the present work, namely on the 
contact angle measurements and the assessment of cell-biomaterials interactions, as 
well as the discussion in view of the current state-of-the-art.  
1. Surface Characterization  
Biomaterials performance depends largely on the protein adsorption which will 
influence the future responses of the host to the biomaterial. Controlling these 
interfacial phenomena by surface modification has become crucial in the development 
of biomaterials for implantation purposes. (63)  
 As mentioned in Chapter 1, PDMS is a hydrophobic material, which is prone to 
adsorb proteins or small hydrophobic molecules. Due to this limitation, PDMS was 
modified by ATRP in order to obtain a more hydrophilic surface. Surface contact angles 
were measured, and the surfaces were observed by AFM to confirm the occurrence of 
a successful surface modification. AFM was also used to visualize the same surfaces 
after fibronectin coating and after cell adhesion. 
1.1. Contact Angles 
 The water contact angles were measured in 5 independent modified PDMS 
surfaces, and 3 measurements were carried out for each independent sample. 
Regarding the unmodified PDMS, 2 independent surfaces were tested, also with 3 
measurements for each sample. The results obtained for the contact angles 
measurement in both unmodified and modified PDMS are gathered in Table 3. 
Table 3. Contact angles measured for the modified and unmodified PDMS. Results represent the 
average of 5 (modified PDMS) and 2 (unmodified PDMS) independent measures ± standard 
deviation. 
 Contact Angle 
Modified PDMS 68.1 ± 6.3 
Unmodified PDMS 88.3 ± 2.7 
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For the unmodified PDMS, an 88.3 ± 2.7 water contact angle is observed, thus 
demonstrating its hydrophobic character. According to the literature, the contact angle 
formed between deionized water and the PDMS is usually around 105°, which means 
that the contact angle represented in Table 3 is low. (19; 64; 65) However, Armani and 
coworkers referred that a contact angle between 90 and 120° can be measured. (66) 
Usually, the 90° contact angle corresponds to the receding contact angle, which is the 
smallest possible angle. This angle is measured when the minimum volume necessary 
to form a water droplet in the surface is used. (67) Thus, the measured contact angle 
may be low due to the use of a small water volume. Considering the standard 
deviation, the contact angle measured in the unmodified PDMS samples is in 
accordance to the literature. For example, Chen and co-workers (2004) reported a 
contact angle of 89° for the PDMS. (67)  
On the other hand, the modified PDMS presented a 68.1 ± 6.3 water contact 
angle value, which is lower than the one obtained for the unmodified sample. The 
statistical analysis of the data demonstrates that there is a significant statistical 
difference between both unmodified and modified samples (p < 0.05). This lower 
contact angle value indicates that the surface is more hydrophilic, thus confirming the 
existence of PEGMA brushes at the surface, and therefore a successful modification 
procedure. Although this contact angle is close to the optimal contact angle for the best 
cell adhesion (60°), the value is still higher, which can influence cell adhesion. (68)  
Furthermore, a significant statistical difference was observed when comparing 
the different modified samples (p < 0.05). This result indicates that the coating varies 
from surface to surface, which suggests that the coating technique used was not 
reproducible. The non-reproducibility can be explained by the difficulty in controlling the 
homogeneity of the polymer brushes formed in the surface, due to chain breaking that 
may occur during the propagation step. (69)  
1.2. AFM 
The topography of a modified surface is an extremely important parameter to be 
assessed, because it affects directly protein adsorption and cell adhesion and 
proliferation on the surface. Atomic force microscopy (AFM) is an extremely useful tool 
that allows studying the modified surfaces. This type of microscopy provides a real 
image of the surface morphology and nanostructure and topographical information 
about surface roughness. 
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In order to observe the surface topography of the modified PDMS and to assess 
if the fibronectin coating is present, pictures from the modified PDMS were taken 
before and after adding fibronectin to the coating. The pictures are illustrated in Figure 
17. 
 
Figure 17. Images obtained by atomic force microscopy (AFM) from the modified PDMS without 
(left) and with (right) a fibronectin coating. Both the pictures correspond to an area of 5 x 5 µm. 
Surface roughness is represented between 0 and 200 µm.   
 From Figure 17, it is possible to observe that the PEGMA coating resulted in a 
surface with a high roughness, with coating heights that can reach more than 100 nm. 
No control (unmodified PDMS) was observed, once the main goal of this experiment 
was to assess if the fibronectin was adsorbing to the PEGMA coating. However, from 
literature it is known that the common roughness of bare PDMS is around 0.52 nm. (29; 
67) Since a roughness higher than 100 nm is observed in the modified PDMS, it is 
possible to conclude that the ATRP procedure resulted in the coating of the PDMS 
surface with dense and long PEGMA brushes. From the high roughness observed, it is 
possible to conclude that ATRP is a suitable technique to coat PDMS surface. 
However, a roughness between 100 nm and 1 µm (submicron roughness) can have a 
dual effect on cell adhesion, growth, viability and maturation. Zhao et al (2006) 
concluded that a submicron roughness in titanium surfaces lead to a lower cell 
adhesion and spreading comparing to the flatter surface. Though, the cells adhered to 
the submicron roughness surface produced more factors that are responsible for 
promoting cell differentiation. (70) Thus, the surface roughness that was observed can 
be responsible for a lower cell density. 
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After incubating the surfaces with fibronectin, the surfaces were again observed 
with AFM (Figure 17, right side). No considerable differences in the surface roughness 
are observed. However, Hull and co-workers (2008) determined the roughness of 
fibronectin adsorbed to a surface (1 cm x 1 cm). The researchers tested different 
concentrations of fibronectin and reached a range of roughness from 7 to 11 nm 
(concentrations of fibronectin from 1 to 100 µg/ml). (71)  
 In the current experiment a fibronectin concentration of 5 µg/ml was used, so an 
increase in the surface roughness should be less than 11 nm. The surface roughness 
before the fibronectin adsorption was higher than 100 nm, which would mean an 
increase in the roughness of around 10%. In this case, it is not possible to confirm if the 
fibronectin is or not adsorbed to the PEGMA, thus hampers to draw any conclusion 
regarding the fibronectin coating. 
 After coating the surfaces with fibronectin, they were seeded with cells and 
incubated. After the incubation period, the surfaces were incubated with ultra-pure 
water in order to detach the cells from the surface. The surfaces were then analyzed 
with AFM to observe if there were any changes in the topography, indicating that some 
coating degradation could be occurring during its incubation with cells. The results are 
illustrated in Figure 18.  
 
Figure 18. Images obtained by atomic force microscopy (AFM) from the modified PDMS with a 
fibronectin coating after cell seeding. The picture on the left has a normal resolution and 
corresponds to an area of 5 x 5 µm. The picture on the right is a 3D picture from a high resolution 
picture taken from the surface. 
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From Figure 18, no visible changes in the surface topography could be 
observed. These results suggest that there was no degradation of the coating during its 
incubation with cells. Nevertheless, the fact that the PDMS surface is coated with 
PEGMA brushes, which makes the surface coating non homogeneous, difficult the 
confirmation of such surface degradation 
2. Surface Cytotoxicity  
In order to evaluate if leachable compounds were being released from the 
surfaces or if there were some compounds that were not completely washed from the 
surfaces after the modification procedure, thus interfering with the cell-biomaterials 
interactions, the surfaces cytotoxicity was evaluated (for details see section 3). Two 
complementary assays were used, namely MTT (colorimetric assay to evaluate cell 
metabolism) and CV (colorimetric assay to evaluate viable cells). The ratio between 
these values was used to determine the metabolism per cell (Figures 19 and 20). 
These results allowed monitoring the biochemical activity of viable cells. (48) The first 
assessment was conducted with the fibroblasts. 
 
 
Figure 19. Ratio between the MTT values and CV values for each dilution of the medium in contact 
with washed and non-washed modified PDMS surfaces. Control consists of the fibroblasts seeded 
in fresh medium. Results correspond to the average of 3 independent assays ± standard deviation. 
 From Figure 19 it is possible to observe the different metabolism per cell 
present in the control and the testing samples. Through statistical analysis (ANOVA), it 
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is possible to determine that there is a significant statistical difference between the 
control and the wells with medium incubated with both the washed and non-washed 
surfaces (p < 0.05). This increase in the metabolic activity per cell is due to an increase 
in the MTT. The CV values are similar in the different samples, which indicate that 
there is a higher cell metabolism in the different testing samples than in the control. 
These results point to the presence of some compound in the medium that is 
stimulating the fibroblasts and increasing their metabolic activity. 
Huang et al (2011) also observed an increase in the metabolic activity when 
they seeded hepatocytes with modified polyester (PES) surfaces. In their experiment, 
this increase in the metabolic activity indicated a stronger adhesion of the cells to the 
modified PES which resulted in higher numbers of cellular adhesion and, consequently, 
a higher metabolism. (72) However, in the current work the fibroblasts were not seeded 
in contact with the modified PDMS, and therefore the results are not comparable. Since 
in the current study, the only variable condition in the experiment was the medium with 
which the cells were incubated, this means that only the presence of some compound 
(leachable) on the medium can be the cause of an increase in the cellular metabolism. 
Comparing the results from the wells with medium incubated with the washed 
surfaces and the results from the wells with medium incubated with the non-washed 
surfaces, there is a statistically significant difference (p < 0.05). This indicates that a 
washing procedure prior to cell seeding introduces differences in the metabolism per 
cell. Observing Figure 19, a higher metabolism per cell is present in the wells with 
medium incubated with surfaces submitted to a washing procedure. This result 
indicates that the differences observed may not result from an increase in cell 
metabolism due to some leachable compound. If some compound released from the 
surfaces was stimulating the cells, the washed surfaces should present a lower 
metabolism per cell. However, the metabolism is higher. Thus, the higher metabolism 
may result from some interference of some medium chemicals in the MTT 
measurement, which results in a higher activity of the enzyme responsible for MTT 
reduction. (73)  
 Also, there is a significant statistical difference (p < 0.05) between the results 
obtained for the wells with different dilutions of the medium incubated with the non-
washed surfaces. The metabolic activity per cell decreases with increasing dilutions, 
which indicates once more that the non-washed surfaces release some compound that 
stimulates the fibroblasts. Regarding the washed surfaces, no significant statistical 
difference (p > 0.05) between the different dilutions of the medium are observed.  This 
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discrepancy in the results suggests some arbitrary interference of a medium compound 
in the MTT assay.    
Similar results were obtained in the same experiment conducted with HUVECs 
(Figure 20).  
 
Figure 20. Ratio between the MTT values and CV values for each dilution of the medium in contact 
with washed and non-washed modified PDMS surfaces. Control consists of the HUVECs seeded in 
fresh medium. Results correspond to the average of 3 independent assays ± standard deviation. 
 The results illustrated in Figure 20 show a similar tendency to the results 
obtained for the fibroblasts (Figure 19).  However, for the HUVECs, the MTT and the 
CV show a similar variation, which indicates that any increase in the metabolic activity 
per cell is the result of both the increase in the MTT measurement and the CV 
measurement. For the HUVECs, there is a significant statistical difference (p < 0.05) 
between the wells with the different dilutions of the medium incubated with the washed 
surfaces. On the other hand, no significant statistical difference (p > 0.05) is observed 
between the wells with the dilutions of the medium incubated with the non-washed 
surfaces. This trend suggests that an inefficient homogenization of the cells suspension 
before distribution through the wells may be on the basis of the observed differences.   
In order to evaluate if the incubation time could result in different values of 
metabolism per cell and decrease the interferences observed, some changes were 
introduced in the experimental protocol. These experiments were conducted with both 
fibroblasts and HUVECs cells. Briefly, the medium was incubated with the modified 
PDMS (washed and non-washed) and afterwards it was diluted at different ratios (1:2, 
1:4, 1:8). Moreover, the incubation time of the cells with the different medium was 
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increased to 72 h. The results obtained with this new experimental setup are illustrated 
in Figures 21 and 22. 
 
Figure 21. Ratio between the MTT values and CV values for each dilution of the medium in contact 
with washed and non-washed modified PDMS surfaces. Fibroblasts were seeded with medium that 
was previously incubated with modified PDMS and diluted afterwards. Control consists of the 
fibroblasts seeded in fresh medium. Results correspond to the average of 3 independent assays ± 
standard deviation. 
From  Figure 21, no statistically significant differences  (p > 0.05) are observed 
between either the washed and non-wahsed surfaces, the several dilutions in both the 
situations, and both the medium incubated with washed and non-wased surfaces and 
the control. This indicates that the metabolism of fibroblasts in contact with the medium 
incubated with the washed and non-washed modified PDMS after 72 h is similar to the 
results obtained for the control experiment. Therefore, the results suggest that the 
surfaces do not release any cytotoxic compound, either they are previously washed or 
not. Thus, these modified surfaces can be used to assess cell adhesion without 
previous washing and no cytotoxic effect from the surfaces is expected.  
 Regarding the HUVECs, the results obtained with the same experiment are 
represented in Figure 22. Contrarily to what happened in the previous experiment, 
where the results obtained for the fibroblasts and the HUVECs are similar, in this 
experiment there are differences in the results obtained for the different cell lines. 
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Figure 22. Ratio between the MTT values and CV values for each dilution of the medium in contact 
with washed and non-washed modified PDMS surfaces. HUVECs were seeded with medium that 
was previously incubated with modified PDMS and diluted afterwards. Control consists of the 
fibroblasts seeded in fresh medium. Results correspond to the average of 3 independent assays ± 
standard deviation. 
From Figure 22, it is possible to conclude that as observed previously, there is 
no significant statistical difference (p > 0.05) between the wells with medium incubated 
with a washed surface and with a non-washed surface. No statistically significant 
differences are either observed between the different medium dilutions, for both the 
washed and non-washed surfaces. These results are in accordance with the results 
obtained for fibroblasts using the same experimental protocol. 
 However, a significant statistical difference (p < 0.05) is observed between the 
wells with the medium incubated with the washed and non-washed modified PDMS 
and the control wells. The differences result both from an increase in the metabolic 
activity and an increase in the cell viability. Although this indicates that the medium 
incubated with the surfaces stimulates the HUVECs, which become more metabolically 
active and present higher cell viability, the lack of differences between dilutions 
indicates the opposite. Thus, the differences may also result from a defficient 
homogenization of the cell suspension.  
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3. Cell-Biomaterial Interaction 
Assessing the cell morphology and its distribution on the biomaterial surface is 
an important step in the evaluation of the interactions between cells and biomaterials. 
Imaging these interactions may provide significant information about cell phenotype 
and function. (74)  
In order to evaluate the interactions between cells and the modified PDMS 
surfaces, an immunocytochemistry assay was performed as described in the Materials 
& Methods section. The confocal microscopy images shown in Figure 23 were obtained 
in that assay conducted after seeding fibroblasts on wells containing the modified 
PDMS (with and without an additional fibronectin coating) and unmodified PDMS, at 
two distinct time points (48 and 120 h). 
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Figure 23. Images obtained by confocal microscopy of the immunochemistry assay conducted 
after exposing fibroblasts to the modified PDMS for 48 and 120 h. A and B - fibroblasts adhered to 
unmodified PDMS, after 48 and 120 h, respectively. C and D - fibroblasts adhered to modified 
PDMS, after 48 and 120 h, respectively. E and F - fibroblasts adhered to modified PDMS with a 
fibronectin coating, after 48 and 120 h, respectively. 
 Figure 23 clearly demonstrates the differences on the fibroblasts adhesion to 
the different surfaces and at different time points. The green staining represents 
vinculin, a structural protein present in the cytoplasmic side of focal adhesions. In red it 
is possible to observe the fibronectin, and in blue the cell nuclei. It is important to notice 
that the cells present a good and stretched conformation, thus indicating that these 
materials are non-cytotoxic. (75) Regarding the different surfaces, it can be observed 
that there are more cells adhered to the unmodified PDMS (Figure 23A and 23B) as 
compared to the ATRP modified PDMS (Figure 23C and 23D). This result was 
A B 
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expected since the PEGMA brushes introduced at the PDMS surface turned it more 
hydrophilic (see section on contact angles measurements) and should decrease the 
protein adsorption, thus decreasing cell adhesion. As referred by Wu and co-workers 
(2008), PDMS hydrophobic nature makes it prone to the adhesion of proteins, which is 
enhanced by the use of serum in the culture medium, thus inducing cell adhesion. On 
the other hand, hydrophilic surfaces have lower levels of protein adsorption, which 
leads to lower cell adhesion levels. (63)   
 The same trend is observed comparing modified PDMS with and without a 
fibronectin coating. Fibronectin is a glycoprotein that binds to the cell integrins, thus 
promoting adhesion. This glycoprotein contains the sequence RGD, which is necessary 
for focal adhesion formation. Focal adhesions are known to be critical for cell survival. 
(76) So, as expected, more cells are adhered to the modified PDMS surface with a 
fibronectin coating (Figure 23E and 23F).  
Finally, comparing the unmodified PDMS with the modified PDMS with a 
fibronectin coating, the differences found are not clear although it is possible to 
visualize a better conformation (more stretched) of the fibroblasts in the second case. 
(75) As discussed above, this can be explained by the presence of the fibronectin that 
is well-known to promote cell adhesion. 
 Regarding the stained structures, in all the pictures it is possible to observe 
assembled fibronectin fibers, which got organized in networks with increasing density 
over time. This indicates a good cell attachment to the surfaces. (48) Vinculin can also 
be observed, but no focal adhesions (patches containing vinculin) are present. It is 
possible to observe that both the proteins seem to be co-localized after 120 h and, as 
reported by Singer (1982), fibronectin-vinculin complexes might correspond to focal 
adhesions. This indicates that even though vinculin patches are not visible, the focal 
adhesions may be present. (77)  
 Cell proliferation is present because, comparing the results obtained for the 
different time points, cell density increases for all the surfaces. This also indicates the 
presence of focal adhesions, which are necessary for cell spreading, although these 
ones are not visible. 
 After obtaining confocal images of the cells adhered to the surfaces, the nuclei 
in each image were counted and it was possible to compare the average number of 
cells adhered in the different time points and surfaces. The results are illustrated in 
Figure 24.  
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Figure 24. Average number of nuclei counted after 48 and 120 h of cells exposure to unmodified 
PDMS, modified PDMS and modified PDMS with a fibronectin coating. Results correspond to the 
average of 6 counts ± standard deviation. 
 Results gathered in Figure 24 show high standard deviations mainly due to the 
experimental method. In this method, three random pictures were taken to each 
sample (2 samples for each surface). Since cell distribution in the surfaces is not 
homogeneous, these random pictures take into account large variations of cell 
numbers. 
Furthermore, after 48 h, and due to the considerable standard deviation 
observed, the cell adhesion between the different surfaces presents no significant 
statistical difference (p > 0.05).   
After 120 h, significant statistical differences (p < 0.5) between the number of 
cells in the unmodified and modified PDMS, and between the modified PDMS and 
modified PDMS with a fibronectin coating, can be observed. However, no statistically 
significant difference is found between the number of cells adhered to the unmodified 
PDMS and the modified PDMS with a fibronectin coating (p > 0.05). The fact that a 
higher cell adhesion is present in surfaces coated with fibronectin, comparing to the 
PEGMA modified PDMS surfaces, is in accordance with the literature, since the 
fibronectin being a protein that establishes cell adhesion, is known to activate cell 
spreading, proliferation and differentiation. (51) However, no differences are observed 
between the unmodified PDMS and the modified PDMS with adsorbed fibronectin, 
which may be caused by the high standard deviations that were obtained. 
The fact that no significant differences are observed in the first 48 h may be 
related to the explanation suggested by Tziampazis and co-workers (2000). These 
authors suggest that when cells attach to ligands adsorbed in a surface they will be 
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able to rearrange the membrane receptors and the surface ligands, which in the future 
will ease the cell binding to the surface. Therefore, in the beginning few binding sites 
will be available in all the surfaces, but over time, due to the rearrangement of the 
surface ligands, more cells will be able to adhere to the surface and to spread. (78) 
Using suitable software (Scion Image, Scion Corporation, US) it was possible to 
estimate the percentage of fibronectin present at the surfaces in the different time 
points (Figure 25). Quantifying the fibronectin is important because, as referred before, 
this protein contains a necessary peptidic sequence (RGD) that is necessary for focal 
adhesion formation, being an indicator of a higher cell adhesion. (76)  
 
Figure 25. Estimate of the fibronectin percentage present after 48 and 120 h using unmodified 
PDMS, modified PDMS and modified PDMS coated with fibronectin. Results correspond to the 
average of 6 experiments ± standard deviation.  
A higher percentage of fibronectin is an indication of a stronger cell adhesion.  
From Figure 25 it is possible to infer that after 48 h no significant statistical difference 
between the fibronectin percentages in the unmodified PDMS and the modified PDMS 
with a fibronectin coating is observed (p > 0.05). However, significant statistical 
differences (p < 0.05) are present between either the unmodified PDMS and the 
modified PDMS, and the modified PDMS and the modified PDMS with a fibronectin 
coating. Higher percentages of fibronectin are detected in both the unmodified PDMS 
and the modified PDMS with a fibronectin coating, which indicates a stronger cell 
adhesion to these surfaces.  
  After 120 h there is a statistically significant difference between the modified 
PDMS with a fibronectin coating and the other samples (p < 0.05). This result is in 
accordance with the results reported by Webb et al (2000), which concluded that the 
attachment of fibroblasts on a surface is a function of the amount of fibronectin 
                                                                            Chapter 3 Results&Discussion 
 
49 
 
immobilized in the surface. (79) Furthermore, no significant statistical difference (p > 
0.05) is found between the unmodified and the modified PDMS.  
It is possible to conclude that the modified PDMS produces a weaker cell 
adhesion, but when a fibronectin coating is added the strength of the cell adhesion 
increases and a higher fibronectin network is produced over time. 
Once the aim of the present work is to evaluate if the modified PDMS is suitable 
to be used as a vascular graft, the same experiments were conducted using HUVECs 
(human umbilical vein endothelium cells). Figure 26 illustrates the images obtained by 
confocal microscopy in the immunocytochemistry assay. 
 
Figure 26. Images obtained by confocal microscopy of the immunochemistry assay conducted 
after exposing HUVECs to the modified PDMS for 48 and 120 h. A and B - HUVECs adhered to 
unmodified PDMS, after 48 and 120 h, respectively. C - HUVECs adhered to modified PDMS, after 48 
h. D - HUVECs adhered to modified PDMS coated with fibronectin after 48 h. E and F - HUVECs 
adhered to modified PDMS coated with gelatin, after 48 and 120 h, respectively.  
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 Results from Figure 26 reveal that HUVECs behavior when in contact with the 
different surfaces under study is completely different from the fibroblasts. Clearly, few 
cells adhered to the unmodified PDMS (Figure 26A and 26B) even after 120 h. 
Regarding the modified PDMS without (Figure 26C) and with (Figure 26D) a fibronectin 
coating, very few cells adhered after 48 h. In all the previously referred cases, no cells 
could be found after 120 h, consequently no images were taken at that time points.   
The lack of cell adhesion on the unmodified PDMS is expectable, because as 
referred by Kooten and co-workers (2004) endothelial cells don’t adhere to hydrophobic 
surfaces. This lack of cell adhesion is explained by the inaccessibility of adhesion sites 
in the surface. However, with the increase in the hydrophilicity (modified PDMS) a 
higher cell adhesion is expected, because endothelial cells readily form focal 
adhesions on hydrophilic polymers, which is not observed. In a previous work from 
Kooten et al (2004), limitations in the endothelial cell adhesion to hydrophilic polymers 
were also reported. The authors coated a polymeric surface in order to make it more 
hydrophilic and endothelial cells were seeded, but after 24 h these cells began to 
detach. The explanation may be the fact that the anti-fouling properties of PEGMA 
decrease protein adsorption or that there is some decrease in the quality of the coating 
elements associated to the surface aging. (48)  
According to Sanborn et al (2002), the expression of cytoskeletal proteins and, 
in consequence, cell adhesion should be enhanced when a fibronectin coating is 
present (64). However, in the current work cell adhesion was not enhanced by the 
presence of a fibronectin coating. It is unclear what could have caused this lack of cell 
adhesion. In the same work from Kooten et al (2004) above mentioned, when they 
assessed the endothelial cell adhesion on surfaces coated with fibronectin, the 
presence of fibronectin was not enough to avoid cell loss. A possible explanation is 
some malfunction of the gap junction intracellular communication, which is a process 
mediated by the gap junctions that contributes to an optimal rate of cell growth and 
death. (48; 80)  
Only for the modified PDMS coated with gelatin it is found a considerable 
number of cells adhered (Figure 26E and 26F). However, after 120 h the cells show 
morphological signs of apoptosis, which include chromatin condensation and apoptotic 
body formation (Figure 26F). (81) These results clearly demonstrate that throughout 
the days something is causing the occurrence of cell apoptosis.  
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Copper and 2,2’-bipyridine are the catalysts used in the ATRP process, and 
according to the literature 2,2’-bipirydine (chelating ligand) metal complexes (namely 
with gold (III), copper (I/II)) have anti-proliferative effects. (82) Since the modified 
samples, although sterilized, were used without further washing, there is the possibility 
that some trace of these compounds is present in the medium. Thus, it was necessary 
to assess if the surfaces somehow were releasing this kind of compounds to the culture 
medium or if some leachable compounds could be released from the surface, thus 
interfering with adhesion and cell viability. 
To confirm if the HUVEC apoptosis previously observed in the 
immunocytochemistry assay is not an isolated result this assay was repeated. 
Interestingly, the new results do not confirm the occurrence of cell apoptosis.  
These cells were also seeded in the 12 well-plate wells coated with gelatin to 
determine if any cell death could be due to the surface presence. Because cell 
apoptosis occurred between 48 and 120 h, cells were now incubated for 3, 4 and 5 
days, in order to determine in which day they start the apoptotic process. Results are 
illustrated in Figure 27.  
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Figure 27. Images obtained by confocal microscopy of the immunochemistry assay conducted after seeding the HUVECs in different surfaces for 3, 4 and 5 days. A 
and B - HUVECs adhered to the 12 well-plate wells with no gelatin, after 3 and 5 days, respectively. C and D - HUVECs adhered to the 12 well-plate wells with 
gelatin, after 3 and 5 days, respectively. E and F - HUVECs adhered to modified PDMS coated with gelatin after 3 and 5 days, respectively. G and H - HUVECs 
adhered to unmodified PDMS coated with gelatin, after 3 and 5 days, respectively. Pictures from day 4 are not represented, because they didn’t represent any 
additional information. 
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Results from Figure 27 reveal that HUVECs behavior changed relatively to the 
last immunocytochemistry assay performed with these cells (Figure 26). In the current 
experiment no cell apoptosis is observed. However, opposite to the previous results 
(Figure 26) where a good cellular density was achieved, few cells adhered to the 
modified PDMS with a gelatin coating (Figure 27E and 27F). Unger and co-workers 
(2005) also coated PES fibers to increase the adhesion of endothelial cells. Cell 
adhesion in the PES fibers with no coating was weak, and after 36 to 72 h no cells 
were visible. Nevertheless, when the PES fibers were coated with gelatin the cell 
adhesion was enhanced and a higher number of HUVEC could be observed in the 
surface. (83) Therefore, based on these researchers findings, in the present work a 
higher cell adhesion would be expected. Nevertheless, the difficulty in distributing the 
gelatin homogeneously over the surface may lead to significant discrepancies in cell 
adhesion. (84)  
Regarding the lack of cell apoptosis, it can indicate that the previous results 
were isolated cases (outliers). The presence of cell apoptosis in the previous results 
occurred due to unknown and unexpected causes.  
Observing the results of the wells coated with gelatin (Figure 27C and 27D) and 
the wells with no gelatin coating (Figure 27C and 27D), there is a high density of cells 
adhered. There are no differences between the coated and non-coated wells, both with 
a high cell adhesion. This is understandable, because the 12 well-plates used are 
special tissue culture plates composed of treated PS. Thus, a good cell adhesion is 
expected in this material, contrary to the untreated PS. 
 Since the cells adhere and proliferate in the wells of the culture plate and not in 
the modified PDMS, it is possible to conclude that the surfaces under study in the 
present work decrease cell adhesion, which is in accordance with the expectations due 
to the coating with non-adhesive PEGMA brushes. (85) The modified PDMS is then not 
suitable to be used in vascular implants, once it decreases HUVEC adhesion, which 
may lead to an inefficient integration of the vascular graft on the implant site. However, 
it is possible that the anti-fouling properties may lead to a decreased activation of 
different cascade reactions, resulting in a better hemocompatibility. (4)  
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Chapter 4. Conclusions 
In the current work the biocompatibility of modified silicone rubber for vascular 
applications was assessed. Atom transfer radical polymerization (ATRP) was used to 
coat silicone rubber surfaces with polyethylene glycol methacrylate (PEGMA) brushes, 
with the aim of reducing protein adsorption and overcome the PDMS limitations caused 
by its hydrophobicity.  
Regarding the surface modification, it is possible to conclude that the PEGMA 
coating decreased the contact angle, turning the surface more hydrophilic. However, 
differences were found between the modified PDMS samples, indicating that the 
coating is perhaps not uniform. Moreover, by AFM, it was possible to observe that the 
coating presented a roughness higher than 100 nm, therefore ATRP is a suitable 
technique to create brushes on the PDMS surface. However, a high roughness can 
lead to some limitations in cell adhesion. The following experiments showed that the 
modified surfaces could be used to evaluate cell adhesion without previous washing 
since no cytotoxic effect from the surfaces should be expected. 
 From the immunocytochemistry assay, performed to evaluate the interaction of 
HSkF and HUVECs with the modified PDMS, it is possible to conclude that the 
modified PDMS decreases cell adhesion, due to the anti-fouling properties of PEGMA. 
However, when human fibronectin is adsorbed to the modified PDMS surface, HSkF 
adhesion increases On the other hand, the unmodified PDMS shows a higher HSkF 
adhesion than the modified PDMS, which is explainable by the fact that PDMS is 
known to adsorb serum proteins easily.  
In the case of HUVECs, neither the unmodified, modified or modified PDMS with 
adsorbed fibronectin yield any cell adhesion. The lack of cell adhesion on the 
unmodified PDMS is expected, because endothelial cells don’t adhere to hydrophobic 
surfaces.   
The results gathered in the present work show that the modified surfaces 
decrease cell adhesion, which is expected due to the anti-fouling properties of PEGMA. 
For vascular applications, this decrease in HUVEC adhesion may lead to an inefficient 
integration of the vascular graft on the implant site, which makes the modified PDMS 
not suitable to be used in vascular implants. However, it is possible that the anti-fouling 
properties may lead to a decreased activation of different cascade reactions, resulting 
in a better hemocompatibility. 
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Chapter 5. Recommendations and Future work 
The results obtained in the present work showed that ATRP is an appropriate 
technique to create polymer brushes in a polymeric surface. The fact that the PEGMA 
coating gave to the material some anti-fouling properties, may be interesting to some 
applications were no interaction between the material and biomolecules is desirable, 
such as for catheters and dialysis systems.  
The surfaces should be further characterized regarding its homogeneity and 
coating distribution. This characterization could be made by AFM or Scanning electron 
microscopy (SEM) and X-ray Photoelectron Spectroscopy (XPS).  
 If cell adhesion is desired, the interaction between PEGMA and some proteins 
involved in cell adhesion should be studied. The interaction between PEGMA and, for 
example, fibronectin should be clarified. In this work it was not possible to assess if 
fibronectin adsorbs correctly to the PEGMA brushes. A higher resolution in the AFM 
could be used, or alternatively some enzyme assays (as Enzyme-linked 
immunosorbent assay or ELISA).  
 With a vascular application as the aim of the PDMS modification, a coating with 
biomolecules in order to increase the adhesion of endothelial cells could be the 
solution. In this case, the interaction of the material with other cell type, as 
macrophages, could be interesting. The blood coating and platelets formation in the 
presence of the biomaterial could also be crucial to determine its applicability as a 
vascular graft. A possible hemocompatibility could be measuring fluorescent labelled 
platelets adhered to the surface. 
 Finally, the techniques used to determine the cell adhesion to the surface could 
be complemented. Some proliferation testing, as the measurement of Ki67 gene by the 
cells using ELISA, could be performed. The presence of some proteins (such as 
cadherins and focal adhesion kinase) in the cells could be determined using Western 
Blotting. Furthermore, based on the high metabolism and cell apoptosis that were 
observed, some genotoxicity tests should also be performed, in order to evaluate the 
biosafety of the surfaces under study. 
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